SEC Info  
  Home     Search     My Interests     Help     Sign In     Please Sign In  
 
Database maintenance is being performed.  If something doesn’t work, please try again shortly.

Hudson Physical Therapy Services In, et al. · S-4 · On 10/17/03

Filed On 10/17/03 2:52pm ET   ·   SEC Files 333-109776, -01, -02, -03, -04, -05, -06, -07, -08, -09, -10, -100, -101, -102, -103, -104, -105, -106, -107, -108, -109, -11, -110, -111, -112, -113, -114, -115, -116, -117, -118, -119, -12, -120, -121, -122, -123, -124, -125, -126, -127, -128, -129, -13, -130, -131, -132, -133, -134, -135, -136, -137, -138, -139, -14, -140, -141, -142, -143, -144, -145, -146, -147, -148, -149, -15, -150, -151, -152, -153, -154, -155, -156, -157, -158, -159, -16, -160, -161, -162, -163, -164, -165, -166, -167, -168, -169, -17, -170, -171, -172, -173, -174, -175, -176, -177, -178, -179, -18, -180, -181, -182, -183, -184, -185, -186, -187, -188, -189, -19, -190, -191, -192, -193, -194, -195, -196, -197, -198, -199, -20, -200, -201, -202, -203, -204, -205, -206, -207, -208, -209, -21, -210, -211, -212, -213, -214, -215, -216, -217, -218, -219, -22, -220, -221, -222, -223, -224, -225, -226, -227, -228, -229, -23, -230, -231, -232, -233, -234, -235, -236, -237, -238, -239, -24, -240, -241, -242, -243, -244, -245, -246, -247, -248, -249, -25, -250, -251, -252, -253, -254, -26, -27, -28, -29, -30, -31, -32, -33, -34, -35, -36, -37, -38, -39, -40, -41, -42, -43, -44, -45, -46, -47, -48, -49, -50, -51, -52, -53, -54, -55, -56, -57, -58, -59, -60, -61, -62, -63, -64, -65, -66, -67, -68, -69, -70, -71, -72, -73, -74, -75, -76, -77, -78, -79, -80, -81, -82, -83, -84, -85, -86, -87, -88, -89, -90, -91, -92, -93, -94, -95, -96, -97, -98   ·   Accession Number 893220-3-1682

  in   Show  and 
Help... Wildcards:  ? (any letter),  * (many).  Logic:  for Docs: (and), (or);  for Text: (anywhere),  "(&)" (near).
  As Of               Filer                 Filing     As/For/On Docs:Pgs              Issuer               Agent

10/17/03  Hudson Physical Therapy Svcs In   S-4                   20:803                                    Bowne of Philadelphia FA
          Select Air II Inc
          Select Management Services LLC
          Select Rehabilitation Management Services Inc
          Select Specialty Hospital Bloomington Inc
          Select Specialty Hospital Boston Inc
          Select Specialty Hospital Conroe Inc
          Select Specialty Hospital Honolulu Inc
          Select Specialty Hospital Lansing Inc
          Select Specialty Hospital Lee Inc
          Select Specialty Hospital Leon Inc
          Select Specialty Hospital Lexington Inc
          Select Specialty Hospital Macon Inc
          Select Specialty Hospital Marion Inc
          Select Specialty Hospital Orange Inc
          Select Specialty Hospital Palm Beach Inc
          Select Specialty Hospital Saginaw Inc
          Select Specialty Hospital Sarasota Inc
          Select Specialty Hospital Western Missouri Inc
          Select Specialty Hospital Zanesville Inc
          Select Transport Inc
          South Philadelphia Occupational Health Inc
          Victoria Healthcare Inc
          Kessler Rehab of Connecticut Inc
          Kessler Rehabilition of Maryland Inc
          Kessler Rehabilitation of Florida Inc
          Kessler Rehab Centers Inc
          Kessler Rehabilitation Corp
          Argosy Health LLC
          Atra Services Inc
          Community Rehab Centers of Massachusetts Inc
          Core Rehab Management LLC
          CRF Rehabilitation Associates Inc
          Edgewater Rehabilitation Associates Inc
          Horizon Health & Rehabilitation Inc
          Kessler Assisted Living Corp
          Kessler Care Center at Ceder Grove Inc
          Kessler Institute for Rehabilitation Inc
          Kessler Occupational Medicine Centers Inc
          Kessler Physical Therapy & Rehabilitation Inc
          Kessler Rehabilitation Services Inc
          Pennsylvania Rehab Inc
          Physical Therapy Associates Inc
          Wilpage Inc
          Select Specialty Hospital Escambia Inc
          Kessler Care Center at Great Falls Inc
          Kessler Care Center at St Cloud Inc
          Intensiva Hospital of Greater St Louis Inc
          Joyner Sports Science Institute Inc
          Kentucky Rehabilitation Services Inc
          Lynn M Carlson Inc
          Metro Rehabilitation Services Inc
          Michigan Therapy Centre Inc
          Midatlantic Health Group Inc
          Monmouth Rehabilitation Inc
          New Mexico Physical Therapists Inc
          Northside Physical Therapy Inc
          Novacare Health Group LLC
          Novacare Occupational Health Services Inc
          Novacare Outpatient Rehabilitation Inc
          Novacare Outpatient Rehabilitation East Inc
          Novacare Outpatient Rehabilitation West Inc
          Novacare Rehabilitation Inc
          NW Rehabilitation Associates Inc
          PT Services Co
          PT Services Inc
          PT Services Rehabilitation Inc
          Peter Trailov Rpt Physical Therapy Clinic Orthopaedic
          Physical Rehabilitation Partners Inc
          Physical Therapy Enterprises Inc
          Physical Therapy Institute Inc
          Physical Therapy Services of the Jersey Cape Inc
          Physio Associates Inc
          Pro Active Therapy of Ahoskie Inc
          Pro Active Therapy of Gaffney Inc
          Pro Active Therapy of Greenville Inc
          Pro Active Therapy of North Carolina Inc
          Pro Active Therapy of South Carolina Inc
          Pro Active Therapy of Virginia Inc
          Pro Active Therapy of Rocky Mount Inc
          Professional Therapeutic Services Inc
          Quad City Management Inc
          Rci Colorado Inc
          Pro Active Therapy Inc
          Rci Exertec Inc
          Indianapolis Physical Therapy & Sports Medicine Inc
          Rehabclinics Inc
          Joyner Sportsmedicine Institute Inc
          American Transitional Hospitals Inc
          Intensiva Healthcare Corp
          Select Medical Corp
          Select Medical of Ohio Inc
          Select Medical of Pennsylvania Inc
          Affiliated Physical Therapists Ltd
          Select Software Ventures LLC
          Allegany Hearing & Speech Inc
          Select Specialty Hospital Akron Inc
          Select Medical Rehabilitation Clinics Inc
          Select Specialty Hospital Ann Arbor Inc
          Select Specialty Hospital Battle Creek Inc
          Human Performance & Fitness Inc
          Select Specialty Hospital Beech Grove Inc
          Atlantic Rehabilitation Services Inc
          Select Specialty Hospital Central Detroit Inc
          Select Specialty Hospital Charleston Inc
          Select Specialty Hospital Albuquerque Inc
          Select Specialty Hospital Cincinnati Inc
          Select Specialty Hospital Columbus Inc
          Select Specialty Hospital Dallas Inc
          Select Specialty Hospital Denver Inc
          Select Specialty Hospital Durham Inc
          Buendel Physical Therapy Inc
          Select Specialty Hospital Erie Inc
          Cer West Inc
          Select Specialty Hospital Evansville Inc
          Coast Institute Physical Therapy Inc
          Select Specialty Hospital Flint Inc
          Ccisub Inc
          Rci Michigan Inc
          Select Specialty Hospital Fort Smith Inc
          Rci Sport Inc
          Rci Wrs Inc
          Cenla Physical Therapy & Rehabilitation Agency Inc
          Select Specialty Hospital Gadsden Inc
          Center for Evaluation & Rehabilitation Inc
          Select Specialty Hospital Fort Wayne Inc
          Select Specialty Hospital Greensburg Inc
          Select Specialty Hospital Houston Inc
          Rebound Oklahoma Inc
          Select Specialty Hospital Indianapolis Inc
          Redwood Pacific Therapies Inc
          Select Specialty Hospital Jackson Inc
          Select Specialty Hospital Johnstown Inc
          Select Specialty Hospital Kansas City Inc
          Select Specialty Hospital Knoxville Inc
          Select Specialty Hospital Little Rock Inc
          Select Specialty Hospital Louisville Inc
          Select Specialty Hospital Macomb County Inc
          Select Specialty Hospital Memphis Inc
          Select Specialty Hospital Arizona Inc
          Select Specialty Hospital South Dallas Inc
          Select Specialty Hospital Milwaukee Inc
          Select Specialty Hospital Morgantown Inc
          Select Specialty Hospital Nashville Inc
          Select Specialty Hospital New Orleans Inc
          Select Specialty Hospital North Knoxville Inc
          Rehab Advantage Inc
          Select Specialty Hospital Northwest Detroit Inc
          Rehab Managed Care of Arizona Inc
          Rehab Provider Network-California Inc
          Select Specialty Hospital Northwest Indiana Inc
          Rehab Provider Network-East I Inc
          Rehab Provider Network-Georgia Inc
          Select Specialty Hospital Oklahoma City Inc
          Rehab Provider Network-Indiana Inc
          Rehab Provider Network-East II Inc
          Rehab Provider Network-Michigan Inc
          Rehab Provider Network-New Jersey Inc
          Rehab Provider Network-Ohio Inc
          Select Specialty Hospital Oklahoma City East Campus Inc
          Rehab Provider Network-Oklahoma Inc
          Rehab Provider Network-Pennsylvania Inc
          Select Specialty Hospital Omaha Inc
          Rehab Provider Network-Washington Dc Inc
          Center for Physical Therapy & Sports Rehabilitation Inc
          Rehab Provider Network of Colorado Inc
          Select Specialty Hospital Philadelphia Aemc Inc
          Select Specialty Hospital Phoenix Inc
          Center Therapy Inc
          Champion Physical Therapy Inc
          Coplin Physical Therapy Associates Inc
          Crowley Physical Therapy Clinic Inc
          Rehab Provider Network of Florida Inc
          Douglas Avery & Associates Ltd
          Rehab Provider Network of Nevada Inc
          Rehab Provider Network of New Mexico Inc
          Rehab Provider Network of North Carolina Inc
          Rehab Provider Network of Texas Inc
          Elk County Physical Therapy Inc
          Rehab Provider Network of Wisconsin Inc
          Select Specialty Hospital Huntsville Inc
          Rehab/Work Hardening Management Associates Ltd
          Fine Bryant & Wah Inc
          Francis Naselli Jr & Stewart Rich Physical Therapists Inc
          Rehabclinics Galaxy Inc
          Gallery Physical Therapy Center Inc
          Rehabclinics Pta Inc
          Georgia Physical Therapy Inc
          GP Therapy LLC
          Greater Sacramento Physical Therapy Associates Inc
          Grove City Physical Therapy & Sports Medicine Inc
          Gulf Breeze Physical Therapy Inc
          Rehabclinics Spt Inc
          Rehabclinics Abilene Inc
          Hand Therapy Associates Inc
          Rehabclinics Dallas Inc
          Hand Therapy & Rehabilitation Associates Inc
          Rehabclinics Pennsylvania Inc
          Hangtown Physical Therapy Inc
          Hawley Physical Therapy Inc
          Start Inc
          Select Employment Services Inc
          Select Hospital Investors Inc
          Selectmark Inc
          Select Medical of Kentucky Inc
          Select Medical of Maryland Inc
          Select Medical of New Jersey Inc
          Select Medical of New York Inc
          New England Health Group Inc
          Georgia Physical Therapy of West Georgia Inc/GA
          Select Specialty Hospital Pittsburgh Inc
          Select Specialty Hospital Pontiac Inc
          Select Specialty Hospital Reno Inc
          Select Specialty Hospital San Antonio Inc
          Select Specialty Hospital Sioux Falls Inc
          Select Specialty Hospital Topeka Inc
          Select Specialty Hospital Tricities Inc
          Select Specialty Hospital Tulsa Inc
          Select Specialty Hospital Columbus Grant Inc
          Select Specialty Hospital Western Michigan Inc
          Select Specialty Hospital Wichita Inc
          Select Specialty Hospital Wilmington Inc
          Select Specialty Hospital Wyandotte Inc
          Select Specialty Hospital Youngstown Inc
          Select Specialty Hospital Inc
          Select Synergos Inc
          Select Unit Management Inc
          SLMC Finance Corp
          Select Provider Networks Inc
          South Jersey Physical Therapy Associates Inc
          South Jersey Rehabilitation & Sports Medicine Center Inc
          Southpointe Fitness Center Inc
          Southwest Emergency Associates Inc
          Southwest Physical Therapy Inc
          Southwest Therapists Inc
          Sports & Orthopedic Rehalilitation Services Inc
          Stephenson Holtz Inc
          Center for Physical Therapy & Rehabilitation Inc
          TJ Partnership I
          Treister Inc
          Novacare Outpatient Rehabilitation of California Inc
          Valley Group Physical Therapists Inc
          Vanguard Rehabilitation Inc
          Wayzata Physical Therapy Center Inc
          West Penn Rehabilitation Services Inc
          West Side Physical Therapy Inc
          West Suburban Health Partners Inc
          Avalon Rehabilitation & Healthcare LLC
          Select Specialty Hospital Columbus University Inc
          Orthopedic Sports & Industrial Rehabilitation Network Inc
          Yuma Rehabilitation Center Inc
          Athens Sports Medicine Clinic Inc
          Ather Sports Injury Clinic Inc
          Atlantic Health Group Inc

Registration of Securities Issued in a Business-Combination Transaction   ·   Form S-4
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-4         Select Medical Corp.                                HTML  3,013K 
 2: EX-2.5      Agreement and Plan of Merger Dated 09/02/2004          3     72K 
 3: EX-4.4      Indenture Governing 7 1/2% Senior Sub. Notes         166    640K 
 4: EX-4.6      Exchange and Registration Rights Agreement            33    177K 
 5: EX-4.7      Supplemental Indenture Dated As of 09/02/2003         15    106K 
 6: EX-4.8      Assumption Agreement Dated As of 09/02/2003           14    101K 
 7: EX-10.74    Fifth Amendment Dated 07/29/2003 to Credit Agree.     38    127K 
 8: EX-10.75    Purchase Agreement Dated As of July 29, 2003          86    325K 
 9: EX-10.76    Escrow Agreement Dated As of August 12, 2003          18    130K 
10: EX-12.1     Statement of Corporation of Ratio of Earnings          2±    73K 
11: EX-21.1     Subsidiaries of Select Medical Corporation             8     95K 
12: EX-23.1     Consent of Pricewaterhousecoopers Llp                  1     67K 
13: EX-23.2     Consent of Pricewaterhousecoopers Llp                  1     67K 
14: EX-25.1     Statement of Eligibility of Trustee                    4     80K 
15: EX-99.1     Form of Letter of Transmittal                         13    121K 
16: EX-99.2     Form of Notice of Guaranteed Delivery                  4     79K 
17: EX-99.3     Letter to Holder of 7 1/2% Senior Sub. Notes           1     67K 
18: EX-99.4     Letter to Brokers, Dealers, Commercial Banks           2     73K 
19: EX-99.5     Letter to Clients Concerning Offer                     3     74K 
20: EX-99.6     Guidelines for Certification of Taxpayer Ident.        2±    72K 


S-4   ·   Select Medical Corp.


This is an EDGAR HTML document rendered as filed.  [ Alternative Formats ]


Sponsored Ads...

  sv4  

 

As filed with the Securities and Exchange Commission on October 17, 2003


SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549


FORM S-4

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933


Select Medical Corporation

(Exact name of Registrant as specified in its charter)
         
Delaware   8093   23-2872718
(State or Other Jurisdiction
of Incorporation or Organization)
  (Primary Standard Industrial
Classification Code Number)
  (I.R.S. Employer
Identification No.)


4716 Old Gettysburg Road

P.O. Box 2034
Mechanicsburg, Pennsylvania 17055
(717) 972-1100
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)


See Table of Additional Registrants Below


Michael E. Tarvin, Esq.

4716 Old Gettysburg Road
P.O. Box 2034
Mechanicsburg, Pennsylvania 17055
(717) 972-1100
(Name, address including zip code, and telephone number, including area code, of agent for service)


With a Copy to:

Christopher G. Karras, Esq.

Dechert LLP
4000 Bell Atlantic Tower
1717 Arch Street
Philadelphia, Pennsylvania, 19103
(215) 994-4000


        Approximate date of commencement of proposed sale of the securities to the public: As soon as practicable after this Registration Statement becomes effective.

        If the securities being registered on this Form are being offered in connection with the formation of a holding company and there is compliance with General Instruction G, check the following box.    o

        If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.    o

        If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.    o

CALCULATION OF REGISTRATION FEE

                 


Amount Proposed Maximum Proposed Maximum Amount of
Title of each Class of to be Offering Price Aggregate Registration
Securities to be Registered Registered Per Unit Offering Price(1) Fee

7 1/2% Senior Subordinated Notes due 2013
  $175,000,000   100%   175,000,000   $14,157.50

Guarantees(2)
  $175,000,000       (3)


(1) Estimated pursuant to Rule 457(f) under the Securities Act of 1933, as amended, solely for purposes of calculating the registration fee.
 
(2) The other companies listed in the Table of Additional Registrants below have guaranteed, jointly and severally, the 7 1/2% Senior Subordinated Notes Due 2013 being registered hereby. The Guarantors are registering the Guarantees. Pursuant to Rule 457(n) under the Securities Act of 1933, no registration fee is required with respect to the Guarantees.
(3) Not applicable.

         The Registrants hereby amend this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.





 

Select Medical Corporation

Table of Additional Registrants

                 
State of Incorporation IRS Employer
Name or Organization Identification No.



Affiliated Physical Therapists, Ltd. 
    Arizona       86-0489265  
Allegany Hearing and Speech, Inc. 
    Maryland       52-1472846  
American Transitional Hospitals, Inc. 
    Delaware       76-0232151  
Argosy Health, LLC
    Delaware       04-3436823  
Athens Sports Medicine Clinic, Inc. 
    Georgia       58-1442208  
Ather Sports Injury Clinic, Inc. 
    California       93-2539628  
Atlantic Health Group, Inc. 
    Delaware       51-0364566  
Atlantic Rehabilitation Services, Inc. 
    New Jersey       22-2214110  
Atra Services, Inc. 
    Delaware       22-2200045  
Avalon Rehabilitation & Healthcare, L.L.C. 
    Delaware       23-2980113  
Buendel Physical Therapy, Inc. 
    Florida       65-0008000  
C.E.R. — West, Inc. 
    Michigan       38-3027085  
C.O.A.S.T. Institute Physical Therapy, Inc. 
    California       23-2727340  
CRF Rehabilitation Associates, Inc. 
    North Carolina       56-1608094  
CCISUB, Inc. 
    North Carolina       56-1342767  
Cenla Physical Therapy & Rehabilitation Agency, Inc. 
    Louisiana       72-0800244  
Center for Evaluation & Rehabilitation, Inc. 
    Michigan       38-2362109  
Center for Physical Therapy & Sports Rehabilitation, Inc. 
    New Mexico       85-0364910  
CenterTherapy, Inc. 
    Minnesota       41-1255299  
Champion Physical Therapy, Inc. 
    Pennsylvania       25-1713794  
Community Rehab Centers of Massachusetts, Inc. 
    Massachusetts       04-3428648  
Coplin Physical Therapy Associates, Inc. 
    Minnesota       41-1402188  
Core Rehab Management, LLC
    Connecticut       06-1536115  
Crowley Physical Therapy Clinic, Inc. 
    Louisiana       72-1207656  
Douglas Avery & Associates, Ltd. 
    Virginia       54-1323120  
Edgewater Rehabilitation Associates, Inc. 
    Illinois       36-2675582  
Elk County Physical Therapy, Inc. 
    Pennsylvania       25-1694794  
Fine, Bryant & Wah, Inc. 
    Maryland       52-1022420  
Francis Naselli, Jr. & Stewart Rich Physical Therapists, Inc. 
    Pennsylvania       23-2028573  
Gallery Physical Therapy Center, Inc. 
    Minnesota       41-1508202  
Georgia Physical Therapy of West Georgia, Inc. 
    Georgia       58-1827718  
Georgia Physical Therapy, Inc. 
    Georgia       58-1305983  
GP Therapy, L.L.C. 
    Georgia       58-2216877  
Greater Sacramento Physical Therapy Associates, Inc. 
    California       68-0165676  
Grove City Physical Therapy and Sports Medicine, Inc. 
    Pennsylvania       25-1766476  
Gulf Breeze Physical Therapy, Inc. 
    Florida       59-2202550  
Hand Therapy Associates, Inc. 
    Arizona       86-0336407  
Hand Therapy and Rehabilitation Associates, Inc. 
    California       77-0012421  
Hangtown Physical Therapy, Inc. 
    California       94-2259895  
Hawley Physical Therapy, Inc. 
    California       77-0187472  
Horizon Health & Rehabilitation, Inc. 
    Maryland       52-1798670  
Hudson Physical Therapy Services, Inc. 
    New Jersey       22-3144550  
Human Performance and Fitness, Inc. 
    California       93-0948981  
Indianapolis Physical Therapy and Sports Medicine, Inc. 
    Indiana       35-1436134  
Intensiva Healthcare Corporation
    Delaware       43-1690769  
Intensiva Hospital of Greater St. Louis, Inc. 
    Missouri       43-1726282  
Joyner Sports Science Institute, Inc. 
    Pennsylvania       23-2888279  
Joyner Sportsmedicine Institute, Inc. 
    Pennsylvania       23-2696896  
Kentucky Rehabilitation Services, Inc. 
    Delaware       61-1205126  
Kessler Assisted Living Corporation
    New Jersey       22-3390033  
Kessler Care Center at Cedar Grove, Inc. 
    New Jersey       22-3486127  
Kessler Care Center at Great Falls, Inc. 
    New Jersey       22-3486122  
Kessler Care Center at St. Cloud, Inc. 
    New Jersey       22-3486123  
Kessler Institute for Rehabilitation, Inc. 
    New Jersey       22-3486125  
Kessler Occupational Medicine Centers, Inc. 
    Florida       65-0982787  
Kessler Physical Therapy & Rehabilitation, Inc. 
    New Jersey       22-3603168  
Kessler Rehab Centers, Inc. 
    Delaware       04-3177708  
Kessler Rehab of Connecticut, Inc. 
    Connecticut       06-1534737  
Kessler Rehabilitation of Florida, Inc. 
    Florida       58-2451604  
Kessler Rehabilitation of Maryland, Inc. 
    Maryland       52-2169122  
Kessler Rehabilitation Corporation
    Delaware       22-3486128  
Kessler Rehabilitation Services, Inc. 
    New Jersey       22-3705780  


 

                 
State of Incorporation IRS Employer
Name or Organization Identification No.



Lynn M. Carlson, Inc. 
    Arizona       86-0429011  
Metro Rehabilitation Services, Inc. 
    Michigan       38-2371931  
Michigan Therapy Centre, Inc. 
    Michigan       38-2828917  
MidAtlantic Health Group, Inc. 
    Delaware       51-0371296  
Monmouth Rehabilitation, Inc. 
    New Jersey       22-2308963  
New England Health Group, Inc. 
    Massachusetts       04-3296305  
New Mexico Physical Therapists, Inc. 
    New Mexico       85-0284878  
Northside Physical Therapy, Inc. 
    Ohio       31-1039737  
NovaCare Health Group, LLC 
    Delaware       25-1877030  
NovaCare Occupational Health Services, Inc. 
    Delaware       23-2884053  
NovaCare Outpatient Rehabilitation East, Inc. 
    Delaware       23-2862027  
NovaCare Outpatient Rehabilitation, Inc. 
    Kansas       48-0916409  
NovaCare Outpatient Rehabilitation of California, Inc. 
    California       94-2986892  
NovaCare Outpatient Rehabilitation West, Inc. 
    Delaware       23-2862029  
NovaCare Rehabilitation, Inc. 
    Minnesota       36-4071272  
NW Rehabilitation Associates, Inc. 
    Delaware       25-1844938  
P.T. Services Company
    Ohio       34-1726528  
P.T. Services, Inc. 
    Ohio       34-1113297  
P.T. Services Rehabilitation, Inc. 
    Ohio       34-1222395  
Pennsylvania Rehab, Inc. 
    Pennsylvania       23-1939940  
Peter Trailov R.P.T. Physical Therapy Clinic, Orthopaedic Rehabilitation & Sports Medicine, Ltd.
    Illinois       36-3229108  
Physical Rehabilitation Partners, Inc. 
    Louisiana       72-0896478  
Physical Therapy Associates, P.C. 
    Massachusetts       04-2552528  
Physical Therapy Enterprises, Inc. 
    Arizona       86-0695632  
Physical Therapy Institute, Inc. 
    Louisiana       72-1034266  
Physical Therapy Services of the Jersey Cape, Inc. 
    New Jersey       22-3058977  
Physio — Associates, Inc. 
    Pennsylvania       25-1353511  
Pro Active Therapy, Inc. 
    North Carolina       56-1859040  
Pro Active Therapy of Ahoskie, Inc. 
    North Carolina       56-1975154  
Pro Active Therapy of Gaffney, Inc. 
    South Carolina       58-2304811  
Pro Active Therapy of Greenville, Inc. 
    North Carolina       56-1960115  
Pro Active Therapy of North Carolina, Inc. 
    North Carolina       56-1818102  
Pro Active Therapy of Rocky Mount, Inc. 
    North Carolina       56-1916359  
Pro Active Therapy of South Carolina, Inc. 
    South Carolina       58-2304502  
Pro Active Therapy of Virginia, Inc. 
    Virginia       58-2342213  
Professional Therapeutic Services, Inc. 
    Ohio       31-0792815  
Quad City Management, Inc. 
    Iowa       42-1363158  
RCI (Colorado), Inc. 
    Delaware       84-1196213  
RCI (Exertec), Inc. 
    Delaware       23-2726794  
RCI (Michigan), Inc. 
    Delaware       23-2768957  
RCI (S.P.O.R.T.), Inc. 
    Delaware       36-3879849  
RCI (WRS), Inc. 
    Delaware       36-3879850  
Rebound Oklahoma, Inc. 
    Oklahoma       73-1386799  
Redwood Pacific Therapies, Inc. 
    California       77-0325407  
Rehab Advantage, Inc. 
    Delaware       23-2947351  
Rehab Managed Care of Arizona, Inc. 
    Delaware       23-2737890  
Rehab Provider Network — California, Inc. 
    California       95-4418601  
Rehab Provider Network — East I, Inc. 
    Delaware       23-2745660  
Rehab Provider Network — East II, Inc. 
    Maryland       23-2796898  
Rehab Provider Network — Georgia, Inc. 
    Georgia       23-2791215  
Rehab Provider Network — Indiana, Inc. 
    Indiana       35-1900442  
Rehab Provider Network — Michigan, Inc. 
    Michigan       23-2804801  
Rehab Provider Network — New Jersey, Inc. 
    New Jersey       23-2745661  
Rehab Provider Network — Ohio, Inc. 
    Ohio       23-2804807  
Rehab Provider Network — Oklahoma, Inc. 
    Oklahoma       23-2803420  
Rehab Provider Network — Pennsylvania, Inc. 
    Pennsylvania       23-2745659  
Rehab Provider Network — Washington, D.C., Inc. 
    District of Columbia       23-2796900  
Rehab Provider Network of Colorado, Inc. 
    Colorado       93-1204512  
Rehab Provider Network of Florida, Inc. 
    Florida       65-0426653  
Rehab Provider Network of Nevada, Inc. 
    Nevada       23-2790203  
Rehab Provider Network of New Mexico, Inc. 
    New Mexico       74-2796295  
Rehab Provider Network of North Carolina, Inc. 
    North Carolina       56-2099749  
Rehab Provider Network of Texas, Inc. 
    Texas       74-2796265  
Rehab Provider Network of Wisconsin, Inc. 
    Wisconsin       36-4095936  
Rehab/ Work Hardening Management Associates, Ltd. 
    Pennsylvania       23-2644918  


 

                 
State of Incorporation IRS Employer
Name or Organization Identification No.



RehabClinics, Inc. 
    Delaware       13-3595267  
RehabClinics (GALAXY), Inc. 
    Illinois       36-3382403  
RehabClinics (PTA), Inc. 
    Delaware       65-0366467  
RehabClinics (SPT), Inc. 
    Delaware       23-2736153  
RehabClinics Abilene, Inc. 
    Delaware       75-2284952  
RehabClinics Dallas, Inc. 
    Delaware       75-2422771  
RehabClinics Pennsylvania, Inc. 
    Pennsylvania       23-2800212  
S.T.A.R.T., Inc. 
    Massachusetts       04-2710250  
Select Air II, Inc. 
    Delaware       23-2972677  
Select Employment Services, Inc. 
    Delaware       25-1812245  
Select Hospital Investors, Inc. 
    Delaware       51-0402736  
Select Management Services, L.L.C. 
    Delaware       25-1805076  
SelectMark, Inc. 
    Delaware       51-0400776  
Select Medical of Kentucky, Inc. 
    Delaware       25-1820753  
Select Medical of Maryland, Inc. 
    Delaware       23-2906982  
Select Medical of New Jersey, Inc. 
    Delaware       25-1805051  
Select Medical of New York, Inc. 
    Delaware       23-2916448  
    Delaware       25-1820754  
Select Medical of Pennsylvania, Inc. 
    Delaware       23-2896808  
Select Medical Rehabilitation Clinics, Inc. 
    Delaware       25-1883131  
Select Provider Networks, Inc. 
    Delaware       23-2935684  
Select Rehabilitation Management Services, Inc. 
    Delaware       26-0030085  
Select Software Ventures, L.L.C.
    Delaware       25-1874244  
Select Specialty Hospital — Akron, Inc. 
    Delaware       43-1742017  
Select Specialty Hospital — Albuquerque, Inc. 
    Delaware       65-0366469  
Select Specialty Hospital — Ann Arbor, Inc. 
    Missouri       38-3389548  
Select Specialty Hospital — Arizona, Inc. 
    Delaware       25-1821705  
Select Specialty Hospital — Battle Creek, Inc. 
    Missouri       38-3389544  
Select Specialty Hospital — Beech Grove, Inc. 
    Missouri       43-1726278  
Select Specialty Hospital — Bloomington, Inc. 
    Delaware       25-1894394  
Select Specialty Hospital — Boston, Inc. 
    Delaware       61-1458009  
Select Specialty Hospital — Central Detroit, Inc. 
    Delaware       25-1862676  
Select Specialty Hospital — Charleston, Inc. 
    Delaware       25-1866522  
Select Specialty Hospital — Cincinnati, Inc. 
    Missouri       31-1574892  
Select Specialty Hospital — Columbus, Inc. 
    Delaware       25-1813127  
Select Specialty Hospital — Columbus/ Grant, Inc. 
    Delaware       25-1816235  
Select Specialty Hospital — Columbus/ University, Inc. 
    Missouri       31-1476471  
Select Specialty Hospital — Conroe, Inc. 
    Delaware       30-0160729  
Select Specialty Hospital — Dallas, Inc. 
    Delaware       25-1813126  
Select Specialty Hospital — Denver, Inc. 
    Delaware       76-0292237  
Select Specialty Hospital — Durham, Inc. 
    Delaware       25-1822461  
Select Specialty Hospital — Erie, Inc. 
    Delaware       25-1858065  
Select Specialty Hospital — Escambia, Inc. 
    Delaware       03-0508545  
Select Specialty Hospital — Evansville, Inc. 
    Missouri       43-1726283  
Select Specialty Hospital — Flint, Inc. 
    Missouri       38-3329100  
Select Specialty Hospital — Fort Smith, Inc. 
    Missouri       71-0813112  
Select Specialty Hospital — Fort Wayne, Inc. 
    Missouri       35-1994301  
Select Specialty Hospital — Gadsden, Inc. 
    Delaware       13-3682015  
Select Specialty Hospital — Greensburg, Inc. 
    Delaware       25-1855814  
Select Specialty Hospital — Honolulu, Inc. 
    Hawaii       04-3772321  
Select Specialty Hospital — Houston, Inc. 
    Delaware       25-1813124  
Select Specialty Hospital — Huntsville, Inc. 
    Delaware       23-2700468  
Select Specialty Hospital — Indianapolis, Inc. 
    Delaware       25-1813123  
Select Specialty Hospital — Jackson, Inc. 
    Delaware       25-1880780  
Select Specialty Hospital — Johnstown, Inc. 
    Missouri       52-2110603  
Select Specialty Hospital — Kansas City, Inc. 
    Missouri       43-1732618  
Select Specialty Hospital — Knoxville, Inc. 
    Delaware       25-1813122  
Select Specialty Hospital — Lansing, Inc. 
    Delaware       30-0199411  
Select Specialty Hospital — Lee, Inc. 
    Delaware       03-0508552  
Select Specialty Hospital — Leon, Inc. 
    Delaware       03-0508543  
Select Specialty Hospital — Lexington, Inc. 
    Delaware       02-0631042  
Select Specialty Hospital — Little Rock, Inc. 
    Delaware       25-1813121  
Select Specialty Hospital — Louisville, Inc. 
    Delaware       25-1816237  
Select Specialty Hospital — Macomb County, Inc. 
    Missouri       38-3345654  
Select Specialty Hospital — Macon, Inc. 
    Delaware       04-3655021  
Select Specialty Hospital — Marion, Inc. 
    Delaware       03-0508556  


 

                 
State of Incorporation IRS Employer
Name or Organization Identification No.



Select Specialty Hospital — Memphis, Inc. 
    Delaware       25-1813120  
Select Specialty Hospital — Milwaukee, Inc. 
    Delaware       25-1820734  
Select Specialty Hospital — Morgantown, Inc. 
    Delaware       25-1855473  
Select Specialty Hospital — Nashville, Inc. 
    Delaware       25-1813119  
Select Specialty Hospital — New Orleans, Inc. 
    Delaware       25-1862678  
Select Specialty Hospital — North Knoxville, Inc. 
    Missouri       62-1684861  
Select Specialty Hospital — Northwest Detroit, Inc. 
    Delaware       25-1862677  
Select Specialty Hospital — Northwest Indiana, Inc. 
    Missouri       43-1726280  
Select Specialty Hospital — Oklahoma City, Inc. 
    Delaware       25-1813118  
Select Specialty Hospital — Oklahoma City/ East Campus, Inc. 
    Missouri       43-1699215  
Select Specialty Hospital — Omaha, Inc. 
    Missouri       47-0815478  
Select Specialty Hospital — Orange, Inc. 
    Delaware       03-0508558  
Select Specialty Hospital — Palm Beach, Inc. 
    Delaware       03-0508559  
Select Specialty Hospital — Philadelphia/ AEMC, Inc. 
    Missouri       52-2075622  
Select Specialty Hospital — Phoenix, Inc. 
    Delaware       25-1813117  
Select Specialty Hospital — Pittsburgh, Inc. 
    Missouri       23-2911846  
Select Specialty Hospital — Pontiac, Inc. 
    Missouri       38-3389212  
Select Specialty Hospital — Reno, Inc. 
    Missouri       88-0383585  
Select Specialty Hospital — Saginaw, Inc. 
    Delaware       25-1890958  
Select Specialty Hospital — San Antonio, Inc. 
    Delaware       25-1843089  
Select Specialty Hospital — Sarasota, Inc. 
    Delaware       23-3089963  
Select Specialty Hospital — Sioux Falls, Inc. 
    Missouri       91-1773396  
Select Specialty Hospital — South Dallas, Inc. 
    Delaware       25-1855474  
Select Specialty Hospital — Topeka, Inc. 
    Missouri       74-2826467  
Select Specialty Hospital — TriCities, Inc. 
    Delaware       25-1813125  
Select Specialty Hospital — Tulsa, Inc. 
    Delaware       25-1813116  
Select Specialty Hospital — Western Michigan, Inc. 
    Missouri       38-3297128  
Select Specialty Hospital — Western Missouri, Inc. 
    Delaware       61-1458008  
Select Specialty Hospital — Wichita, Inc. 
    Missouri       48-1196430  
Select Specialty Hospital — Wilmington, Inc. 
    Missouri       51-0382465  
Select Specialty Hospital — Wyandotte, Inc. 
    Delaware       25-1862675  
Select Specialty Hospital — Youngstown, Inc. 
    Missouri       34-1880514  
Select Specialty Hospital — Zanesville, Inc. 
    Delaware       03-0508537  
Select Specialty Hospitals, Inc. 
    Delaware       25-1813128  
Select Synergos, Inc. 
    Delaware       25-1813114  
Select Transport, Inc. 
    Delaware       23-2872899  
Select Unit Management, Inc. 
    Delaware       71-0776296  
SLMC Finance Corporation
    Delaware       51-0406794  
South Jersey Physical Therapy Associates, Inc. 
    New Jersey       22-2126713  
South Jersey Rehabilitation and Sports Medicine Center, Inc. 
    New Jersey       22-2544574  
South Philadelphia Occupational Health, Inc. 
    Pennsylvania       23-2777267  
Southpointe Fitness Center, Inc. 
    Pennsylvania       25-1760081  
Southwest Emergency Associates, Inc. 
    Arizona       86-0376633  
Southwest Physical Therapy, Inc. 
    New Mexico       85-0333685  
Southwest Therapists, Inc. 
    New Mexico       85-0278777  
Sports & Orthopedic Rehabilitation Services, Inc. 
    Florida       59-2922487  
Stephenson-Holtz, Inc. 
    California       77-0325407  
The Center for Physical Therapy and Rehabilitation, Inc. 
    New Mexico       85-0349202  
The Orthopedic Sports and Industrial Rehabilitation Network, Inc. 
    Pennsylvania       23-2626897  
TJ Partnership I
    Florida       23-2827568  
Treister, Inc. 
    Ohio       34-1021034  
Valley Group Physical Therapists, Inc. 
    Pennsylvania       23-2081856  
Vanguard Rehabilitation, Inc. 
    Arizona       86-0490865  
Victoria Healthcare, Inc. 
    Florida       25-1897325  
Wayzata Physical Therapy Center, Inc. 
    Minnesota       41-1529147  
West Penn Rehabilitation Services, Inc. 
    Pennsylvania       25-1504470  
West Side Physical Therapy, Inc. 
    Ohio       31-1182791  
West Suburban Health Partners, Inc. 
    Minnesota       41-1631716  
Wilpage, Inc. 
    New Jersey       22-2739039  
Yuma Rehabilitation Center, Inc. 
    Arizona       86-0470129  

The address, including zip code, and telephone number, including area code, of the principal offices of the additional registrants listed above (the “Additional Registrants”) is 4716 Old Gettysburg Road, P.O. Box 2034, Mechanicsburg, Pennsylvania 17055. The telephone number at that address is (717) 972-1100.



 

The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

SUBJECT TO COMPLETION, DATED OCTOBER 17, 2003

PROSPECTUS

OFFER TO EXCHANGE

7 1/2% Senior Subordinated Notes Due 2013 originally issued by Select Medical Escrow, Inc. for new 7 1/2% Senior Subordinated Notes Due 2013

of

SELECT MEDICAL CORPORATION

THE EXCHANGE OFFER WILL EXPIRE AT 5:00 P.M.,

NEW YORK CITY TIME ON                    , 2003, UNLESS EXTENDED.


     Terms of the exchange offer:

  •  We will exchange all old notes that are validly tendered and not withdrawn prior to the expiration of the exchange offer.
 
  •  You may withdraw tenders of old notes at any time prior to the expiration of the exchange offer.
 
  •  We believe that the exchange of old notes will not be a taxable event for U.S. federal income tax purposes, but you should see “Certain United States federal income tax considerations” on page 167 for more information.
 
  •  We will not receive any proceeds from the exchange offer.
 
  •  The terms of the new notes are substantially identical to the old notes, except that the new notes are registered under the Securities Act of 1933 and the transfer restrictions and registration rights applicable to the old notes do not apply to the new notes.


      See “Risk Factors” beginning on page 17 for a discussion of risks that should be considered by holders prior to tendering their old notes.


     Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.

The date of this prospectus is                     , 2003.



 

In making your investment decision, you should rely only on the information contained in this prospectus. We have not authorized anyone to provide you with any other information. If you receive any other information, you should not rely on it.

You should not assume that the information contained in this prospectus is accurate as of any date other than the date on the front cover of this prospectus. The information on our website, located at www.selectmedicalcorp.com, is not part of this prospectus.


Table of contents

         
Summary
    1  
Summary consolidated financial and other data
    13  
Risk factors
    17  
Use of proceeds
    30  
Capitalization
    31  
Unaudited pro forma combined financial information
    32  
Selected consolidated financial and other data
    38  
Management’s discussion and analysis of financial condition and results of operations
    41  
Our business
    62  
Exchange offer
    86  
Management
    96  
Related party transactions
    106  
Principal stockholders
    107  
Description of notes
    109  
Description of other indebtedness
    157  
Book-entry settlement and clearance
    161  
Exchange and registration rights agreement
    164  
Certain United States federal income tax consequences
    167  
Plan of distribution
    171  
Legal matters
    171  
Experts
    171  
Where you can find more information
    172  
Index to consolidated financial statements
    F-1  

Our principal executive offices are located at 4716 Old Gettysburg Road, Mechanicsburg, Pennsylvania, and our telephone number at that address is (717) 972-1100. Our common stock is listed on the New York Stock Exchange under the symbol “SEM.”

Each broker-dealer that receives new notes for its own account pursuant to the exchange offer must acknowledge that it will deliver a prospectus in connection with any resale of new notes. The Letter of Transmittal states that by so acknowledging and by delivering a prospectus, a broker-dealer will not be deemed to admit that it is an “underwriter” within the meaning of the Securities Act of 1933, which we refer to as the Securities Act. This prospectus, as it may be amended or supplemented from time to time, may be used by a broker-dealer in connection with resales of new notes received in exchange for old notes where the old notes were acquired by the broker-dealer as a result of market-making activities or other trading activities. We have agreed that, for a period of 180 days after the expiration date, we will make this prospectus available to any broker-dealer for use in connection with any such resale. See “Plan of distribution.”


Industry and market data

In this prospectus we rely on and refer to information and statistics regarding the healthcare industry. We obtained this information and these statistics from various third-party sources, discussions with our customers and our own internal estimates. We believe that these sources

i



 

and estimates are reliable, but we have not independently verified them and cannot guarantee their accuracy or completeness.

Forward-looking statements

Statements contained in this prospectus that are not historical facts may be forward-looking statements within the meaning of U.S. federal securities law. These statements include, without limitation, statements preceded by, followed by or that include the words “believes,” “expects,” “anticipates,” “estimates,” or similar expressions. Such forward-looking statements reflect management’s beliefs and assumptions and are based on information currently available to management. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The following factors are among those that may cause actual results to differ materially from the forward-looking statements:

  a change in government reimbursement for our services that would affect our revenue;
 
  the failure of our long term acute care hospitals to maintain their status as such, which could negatively impact our profitability;
 
  a government investigation or assertion that we have violated applicable regulations may result in increased costs and a significant use of internal resources;
 
  shortages in qualified nurses could increase our operating costs significantly;
 
  the effect of liability and other claims asserted against us;
 
  conditions in the malpractice insurance market may further increase the cost of malpractice insurance and/or force us to assume even higher self-insured retentions;
 
  private third party payors of our services may undertake cost containment initiatives that would decrease our revenue;
 
  unexpected difficulties in integrating our and Kessler’s operations or realizing the anticipated benefits from the Kessler Acquisition (as described herein);
 
  unforeseen liabilities associated with the Kessler Acquisition; and
 
  future acquisitions may use significant resources and expose us to unforeseen risks.

All subsequent written and oral forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements set forth or referred to above. We are not obligated to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

ii



 

Summary

The summary highlights information contained elsewhere in this prospectus. You should read the entire prospectus carefully, including the financial statements and related notes and the risks of investing discussed under “Risk factors,” before investing.

In this prospectus, “Company,” “Select,” “we,” “our,” and “us,” except as otherwise indicated or as the context otherwise indicates, refer to Select Medical Corporation. With respect to the descriptions of our business contained in this prospectus, such terms refer to Select Medical Corporation and our subsidiaries. The terms “Select Medical Escrow” refers to Select Medical Escrow, Inc., “Kessler” refers to Kessler Rehabilitation Corporation and its subsidiaries and the term “Kessler Acquisition” refers to our acquisition of Kessler as described under the caption “Our business— the Kessler Acquisition.”

The Exchange Offer

On July 29, 2003, Select Medical Escrow issued and sold $175.0 million aggregate principal amount of 7 1/2% Senior Subordinated Notes Due 2013, referred to as the old notes. In connection with that sale, Select and Select Medical Escrow entered into a registration rights agreement with the initial purchasers of the old notes in which we agreed to deliver this prospectus to you and to complete an exchange offer for the old notes. On September 2, 2003, Select Medical Escrow was merged with and into Select—and the separate corporate existence of Select Medical Escrow ceased as of that date and Select assumed all of the obligations and responsibilities of Select Medical Escrow under the old notes. As required by the registration rights agreement, Select is offering to exchange $175.0 million aggregate principal amount of our new 7 1/2% Senior Subordinated Notes Due 2013, referred to as the new notes, the issuance of which will be registered under the Securities Act, for a like aggregate principal amount of old notes. We refer to this offer to exchange new notes for old notes in accordance with the terms set forth in this prospectus and the accompanying letter of transmittal as the exchange offer. You are entitled to exchange your old notes for new notes. We urge you to read the discussions under the headings The exchange offer and “The new notes” in this Summary for further information regarding the exchange offer and the new notes.

Company overview

We are a leading operator of specialty hospitals for long term stay patients in the United States. We are also a leading operator of outpatient rehabilitation clinics in the United States and Canada. As of June 30, 2003, we operated 75 long term acute care hospitals in 24 states and 737 outpatient rehabilitation clinics in 32 states, the District of Columbia and seven Canadian provinces. We began operations in 1997 under the leadership of our current management team, including our co-founders, Rocco A. Ortenzio and Robert A. Ortenzio, both of whom have significant experience in the healthcare industry. Under this leadership, we have grown our business through strategic acquisitions and internal development initiatives, increasing net operating revenue, net income (loss) and EBITDA (as defined in “—Summary of consolidated financial and other data”) from $456.0 million, $(13.1) million and $27.5 million, respectively, for the fiscal year ended December 31, 1999 to $1,126.6 million, $44.2 million and $125.3 million for the fiscal year ended December 31, 2002.

1



 

Recent developments

Kessler Acquisition

On September 2, 2003, we completed the acquisition of all of the outstanding stock of Kessler Rehabilitation Corporation from Henry H. Kessler Foundation, Inc. for $228.3 million in cash, and $1.7 million of assumed indebtedness. The purchase price is subject to a post-closing working capital adjustment as described under the caption “Our business— the Kessler Acquisition.” Through its network of five rehabilitation hospital facilities and 92 outpatient clinics, Kessler is one of the nation’s leading providers of comprehensive rehabilitation care and physical medicine services. As of June 30, 2003, pro forma for the Kessler Acquisition, we would have operated 80 specialty hospitals and 829 outpatient rehabilitation clinics. Additionally, on a pro forma basis, we would have generated net operating revenues, net income and EBITDA of $757.2 million, $29.5 million and $88.6 million, respectively, for the six months ended June 30, 2003.

Select Medical Corporation

We operate our business to satisfy a broad range of healthcare needs through the following divisions:

Specialty hospitals/other (60% of net operating revenue for the six months ended June 30, 2003)

Our long term acute care hospitals treat patients with serious and often complex medical conditions such as respiratory failure, neuromuscular disorders, cardiac disorders, non-healing wounds, renal disorders and cancer. Patients are admitted to our long term acute care hospitals from general acute care hospitals in our markets. The differences in clinical expertise and reimbursement rates provide general acute care hospitals and their physicians with incentives to discharge longer stay, medically complex patients to our facilities. Nearly all of our existing facilities are located in leased space within general acute care hospitals. The leased spaces are commonly referred to as a “hospital within a hospital.” We believe this model provides several advantages to patients, host hospitals, physicians and us:

  Patients benefit from being in a setting specialized to meet their unique medical needs;
 
  In addition to being provided with a place to discharge high-cost, long-stay patients, host hospitals benefit by receiving payments from us for rent and ancillary services;
 
  Physicians affiliated with the host hospital are provided with the convenience of being able to monitor the progress of their patients without traveling to another location; and
 
  We benefit from the ability to operate specialty hospitals without the capital investment often associated with buying or building a freestanding facility. We also gain operating cost efficiencies by contracting with these host hospitals for selected services at discounted rates.

2



 

Outpatient rehabilitation (40% of net operating revenues for the six months ended June 30, 2003)

Our outpatient rehabilitation clinics provide physical, occupational and speech therapy typically to patients with musculoskeletal impairments that restrict their ability to perform normal activities of daily living. We also provide rehabilitation management services and staffing on a contract basis to other healthcare providers. Patients are generally referred or directed to our clinics by a physician, employer or health insurer who believes that a patient can benefit from our services. We believe that our services are attractive to healthcare payors who are seeking to provide the most cost-effective level of care to their enrollees.

Kessler Rehabilitation Corporation

Kessler provides the following services:

Specialty hospitals (54% of Kessler’s revenues for the six months ended June 30, 2003)

Kessler’s specialty hospital services are delivered through four free-standing rehabilitation hospital facilities in New Jersey. In these facilities, Kessler provides services to patients who require intensive rehabilitative care for debilitating injuries including traumatic brain and spinal cord injuries. Patients in Kessler’s specialty hospitals generally require longer stays and a more specialized level of clinical attention than individuals in general acute care hospital settings. Kessler also has a 50% ownership position in a rehabilitation hospital in Maryland which it operates with a joint venture partner. Kessler accounts for this joint venture under the equity method of accounting for investments.

Outpatient rehabilitation (35% of Kessler’s revenues for the six months ended June 30, 2003)

Outpatient rehabilitation services are provided through 92 outpatient rehabilitation clinics. At these clinics, Kessler provides physical, occupational and speech therapy to patients who require rehabilitation services but are well enough to be treated outside of an inpatient setting. Kessler’s clinics are located throughout 10 states in the eastern United States. Additionally, Kessler provides onsite contract rehabilitation services to individuals in third-party institutions such as schools, nursing homes, assisted living facilities, hospitals and the workplace.

Other services (11% of Kessler’s revenues for the six months ended June 30, 2003)

Other services include the sale of home medical equipment, orthotics, prosthetics, oxygen and ventilator systems and infusion/intravenous services. Kessler also operates a 196-bed skilled nursing facility located in New Jersey.

We believe that the Kessler Acquisition provides us significant benefits including:

  •  Highly regarded brand name. Kessler has built a strong reputation and is widely recognized for its leadership in providing quality, comprehensive rehabilitation services. Notably, Kessler’s rehabilitation hospital network, Kessler Institute for Rehabilitation, was ranked as the top rehabilitation hospital in the northeastern United States in 2002, according to a survey of board-certified physicians that was published by U.S. News & World Report. We expect that this strong brand name will enhance our ability to attract patients and strengthen our referral relationships.
 
  •  Comparable specialty hospital business. Kessler’s rehabilitation hospital facilities represent a strong fit with our existing long term acute care hospital business. Both Kessler’s rehabilitation hospital facilities and our long term acute care hospitals

3



 

  provide specialized care to their patient populations and have similar business fundamentals. The addition of Kessler’s rehabilitation hospitals will allow us to reach a broader array of patients and will provide us with an additional platform for future growth.

  •  Greater scale in outpatient rehabilitation. Kessler’s outpatient rehabilitation clinics will provide additional scale to our existing outpatient business, particularly in the eastern United States. Our total number of facilities as of June 30, 2003, pro forma for the Kessler Acquisition, would have increased from 737 to 829. We believe scale enhances our referral network and our ability to negotiate favorable contracts with commercial insurers.
 
  •  Leverage our management team’s expertise. Our management team has extensive experience operating both outpatient rehabilitation clinics and specialty hospitals licensed as rehabilitation hospitals. Prior to co-founding Select, our Executive Chairman, Rocco Ortenzio, and our President and Chief Executive Officer, Robert Ortenzio co-founded Continental Medical Systems, Inc. (“CMSI”) a publicly traded rehabilitation hospital company. They managed and developed this company from its inception in 1986 until it was sold in 1995.

Competitive strengths

  •  Leading market position. Since beginning our operations in 1997, we believe that we have developed a reputation as a high quality, cost-effective health care provider in the markets we serve. We are a leading operator of specialty hospitals for long term stay patients in the United States and a leading operator of outpatient rehabilitation clinics in the United States and Canada. As of June 30, 2003, we operated 75 long term acute care hospitals with 2,758 available licensed beds in 24 states, and we also operated 737 outpatient rehabilitation clinics in 32 states, the District of Columbia and seven Canadian provinces. The Kessler Acquisition provides five inpatient rehabilitation facilities, an additional 92 outpatient rehabilitation clinics and a widely recognized brand name with a high quality reputation. Our leadership position allows us to attract patients, aids us in our marketing efforts to payors and referral sources and helps us negotiate favorable payor contracts.
 
  •  Experienced and proven management team. Prior to co-founding Select and CMSI, our Executive Chairman founded and operated two other healthcare companies focused on rehabilitation services. Our five senior operations executives have an average of 25 years of experience in the healthcare industry. In addition, 17 of the Company’s 28 officers previously worked together at CMSI.
 
  •  Proven financial performance. We have established a track record of improving the performance of the facilities we operate. A significant reason for our strong operating performance over the past several years has been our disciplined approach to growth and intense focus on cash flow generation and debt reduction:

  net operating revenues, net income (loss) and EBITDA (excluding the Kessler Acquisition) have grown from $456.0 million, $(13.1) million and $27.5 million, respectively, for the fiscal year ended December 31, 1999 to $1,126.6 million, $44.2 million and $125.3 million, respectively, for the fiscal year ended December 31, 2002;

4



 

  accounts receivable days outstanding have decreased from 119 as of December 31, 1999 to 56 as of June 30, 2003; and
 
  our ability to reduce our ratio of total debt to EBITDA from 3.7x as of December 31, 2000 to 2.1x as of December 31, 2002.

  •  Experience in successfully completing and integrating acquisitions. Since we began operations in 1997, we have completed three significant acquisitions for approximately $366.4 million in aggregate consideration (not including the Kessler Acquisition). We believe that we have significantly improved the operating performance of the facilities we have acquired by applying our standard operating practices to the acquired businesses.
 
  •  Significant scale. By building significant scale in our specialty hospitals and outpatient rehabilitation clinics, we have been able to leverage our operating costs by centralizing administrative functions at our corporate office. Additionally, we believe that our size improves our ability to negotiate favorable outpatient contracts with commercial insurers.
 
  •  Multiple business lines and geographic diversity. We have a leading presence in two attractive segments of the healthcare industry, which we believe diversifies our business risk. Because we provide inpatient care in our specialty hospitals and outpatient care in our rehabilitation clinics, we do not rely exclusively on a single business line for our net operating revenues, operating profits or EBITDA. Our geographic diversification and the mix of our business also reduces our exposure to any single governmental or commercial reimbursement source.
 
  •  Demonstrated development expertise. From our inception through June 30, 2003, we have developed 40 new long term acute care hospitals and 164 outpatient rehabilitation clinics. These initiatives have demonstrated our ability to effectively identify new opportunities and implement start-up plans.

Our strategy

Specialty hospitals

The key elements of our specialty hospital strategy are to:

  •  Provide high quality and cost effective care. To effectively address the complex nature of our patients’ medical conditions, we have developed specialized treatment programs focused on their needs. Additionally, our staffing models are designed to ensure that patients have access to the necessary level of clinical attention and that our resources are being deployed in an efficient, cost- effective manner. The quality of the patient care we provide is continually monitored using several measures including clinical outcomes as well as patient, payor and physician satisfaction surveys.
 
  •  Reduce operating costs. We continually seek to improve operating efficiency and reduce costs at our hospitals by standardizing and centralizing key administrative functions. We believe that by optimizing staffing based on our occupancy and the clinical needs of our patients, we can lower our variable cost per patient. Additionally, as part of our operating philosophy, we continue to focus on initiatives that will reduce expenses, such as group purchasing arrangements to receive discounts for pharmaceutical and medical supplies.

5



 

  •  Increase higher margin commercial volume. We typically receive higher reimbursement rates from commercial insurers than we do from the federal Medicare program. As a result, we work to expand relationships with insurers to increase commercial patient volume. Although the level of care we provide is complex and staff intensive, we typically have lower operating expenses at our existing hospitals because we provide a much narrower range of patient services than a general acute care hospital. As a result of these lower costs, we offer more attractive rates to commercial payors. We also believe that we offer commercial enrollees customized treatment programs not offered in traditional acute care facilities.
 
  •  Develop new long term acute care hospitals. Our goal is to develop 8 to 10 new long term acute care hospitals each year using primarily our “hospital within a hospital” model by leasing space from general acute care hospitals with leading market positions. We seek to contract with various types of general acute care hospitals, including for-profit, not-for-profit and university affiliates. We intend to continue to expand our high quality facility base while maintaining our high standards of care.
 
  •  Pursue opportunistic acquisitions. In addition to our development initiatives, we intend to grow our network of specialty hospitals through strategic acquisitions. We adhere to selective criteria in our analysis and have historically been able to obtain assets for what we believe are attractive valuations. We have a focused team of professionals that formulates and executes an integration plan, and we have generally been able to increase margins at acquired facilities by streamlining various functions and standardizing our staffing models.

Outpatient rehabilitation

The key elements of our outpatient rehabilitation strategy are to:

  •  Increase market share. Having a strong market share in our local markets allows us to benefit from heightened brand awareness, economies of scale and increased leverage when negotiating payor contracts. To increase our market share, we seek to expand the services and programs we provide and generate loyalty with patients and referral sources by providing high quality care and strong customer service. We intend to leverage the scale we will achieve through the acquisition of the Kessler outpatient clinics to enhance this strategy.
 
  •  Optimize the profitability of our payor contracts. We continually review new and existing payor contracts to determine how each of the contracts affects our profitability. We create a retention strategy for each of our top performing contracts and a re-negotiation strategy for contracts that do not meet our defined criteria.
 
  •  Grow through new development and acquisitions. We intend to open new clinics in our current markets where we believe we can benefit from existing referral relationships and brand awareness to produce incremental growth and operating leverage. Additionally, we intend to continually evaluate acquisition opportunities, such as Kessler, that may enhance the scale of our business and expand our geographic reach.
 
  •  Maintain strong employee relations. We seek to retain, motivate and educate our employees whose relationships with referral sources, such as physicians and healthcare case managers, are key to our success. We attempt to motivate them by implementing

6



 

  a performance-based program, a defined career path, timely and open communication on company developments, and internal training programs. We also focus on empowering our employees by giving them a high degree of autonomy in determining local market strategy. This management approach reflects the unique nature of each market we operate in and the importance of encouraging our employees to assume responsibility for their clinic’s performance.

7



 

The exchange offer

 
Notes offered $175,000,000 aggregate principal amount of 7 1/2% Senior Subordinated Notes Due 2013 of Select Medical Corporation. The terms of the new notes and old notes are identical in all material respects, except for transfer restrictions and registration rights relating to the old notes.
 
The exchange offer We are offering the new notes to you in exchange for a like principal amount of old notes. Old notes may be exchanged only in integral multiples of $1,000. We intend by the issuance of the new notes to satisfy our obligations contained in the Exchange and Registration Rights Agreement.
 
Expiration date; Withdrawal of tender The exchange offer will expire at 5:00 p.m., New York City time, on                     , 2003, or such later date and time to which it may be extended by us. The tender of old notes pursuant to the exchange offer may be withdrawn at any time prior to the expiration date of the exchange offer. Any old notes not accepted for exchange for any reason will be returned without expense to the tendering holder thereof as promptly as practicable after the expiration or termination of the exchange offer.
 
Conditions to the exchange offer Our obligation to accept for exchange, or to issue new notes in exchange for, any old notes is subject to customary conditions relating to compliance with any applicable law or any applicable interpretation by the staff of the Securities and Exchange Commission, the receipt of any applicable governmental approvals and the absence of any actions or proceedings of any governmental agency or court which could materially impair our ability to consummate the exchange offer. We currently expect that each of the conditions will be satisfied and that no waivers will be necessary. See “The exchange offer— Conditions to the exchange offer.”
 
Procedures for tendering old notes If you wish to accept the exchange offer and tender your old notes, you must complete, sign and date the Letter of Transmittal, or a facsimile of the Letter of Transmittal, in accordance with its instructions and the instructions in this prospectus, and mail or otherwise deliver such Letter of Transmittal, or the facsimile, together with the old notes and any other required documentation, to the exchange agent at the address set forth herein. See “The exchange offer— Procedures for tendering old notes.”
 
Use of proceeds We will not receive any proceeds from the exchange offer.
 
Exchange agent U.S. Bank Trust National Association is serving as the exchange agent in connection with the exchange offer.

8



 

 
Federal income tax Consequences The exchange of notes pursuant to the exchange offer should not be a taxable event for federal income tax purposes. See “Certain United States federal income tax consequences.”

9



 

Consequences of exchanging old notes pursuant to the exchange offer

Based on certain interpretive letters issued by the staff of the Securities and Exchange Commission to third parties in unrelated transactions, we are of the view that holders of old notes (other than any holder who is an “affiliate” of our company within the meaning of Rule 405 under the Securities Act) who exchange their old notes for new notes pursuant to the exchange offer generally may offer the new notes for resale, resell such new notes and otherwise transfer the new notes without compliance with the registration and prospectus delivery provisions of the Securities Act, provided:

  •  the new notes are acquired in the ordinary course of the holders’ business;
 
  •  the holders have no arrangement with any person to participate in a distribution of the new notes; and
 
  •  neither the holder nor any other person is engaging in or intends to engage in a distribution of the new notes.

Each broker-dealer that receives new notes for its own account in exchange for old notes must acknowledge that it will deliver a prospectus in connection with any resale of the new notes. See “Plan of distribution.” In addition, to comply with the securities laws of applicable jurisdictions, the new notes may not be offered or sold unless they have been registered or qualified for sale in the applicable jurisdiction or in compliance with an available exemption from registration or qualification. We have agreed, under the Exchange and Registration Rights Agreement and subject to limitations specified in the Exchange and Registration Rights Agreement, to register or qualify the new notes for offer or sale under the securities or blue sky laws of the applicable jurisdictions as any holder of the notes reasonably requests in writing. If a holder of old notes does not exchange the old notes for new notes according to the terms of the exchange offer, the old notes will continue to be subject to the restrictions on transfer contained in the legend printed on the old notes. In general, the old notes may not be offered or sold, unless registered under the Securities Act, except under an exemption from, or in a transaction not subject to, the Securities Act and applicable state securities laws. Holders of old notes do not have any appraisal or dissenters’ rights under the Delaware General Corporation Law in connection with the exchange offer. See “The exchange offer— consequences of failure to exchange; Resales of new notes.”

The old notes are currently eligible for trading in the Private Offerings, Resales and Trading through Automated Linkages (PORTAL) market. Following commencement of the exchange offer but prior to its completion, the old notes may continue to be traded in the PORTAL market. Following completion of the exchange offer, the new notes will not be eligible for PORTAL trading.

10



 

The new notes

The terms of the new notes and the old notes are identical in all material respects, except for transfer restrictions and registration rights relating to the old notes.

 
Issuer Select Medical Corporation
 
Maturity date August 1, 2013.
 
Interest payment dates August 1 and February 1 of each year, commencing February 1, 2004.
 
Optional redemption On or after August 1, 2008, Select may redeem some or all of the new notes at the redemption prices listed in the section entitled “Description of notes— Optional redemption.” Select may not redeem the new notes before August 1, 2008, except that at any time before August 1, 2006, Select may redeem up to 35% of the original principal amount of the new notes with the proceeds of certain offerings of common equity at a redemption price equal to 107.5% of the principal amount of the new notes, together with accrued and unpaid interest, so long as 65% of the original principal amount of the new notes remain outstanding after each permitted redemption made with equity proceeds.
 
Change of control Upon a change of control, each holder of the new notes may require Select to repurchase such holder’s notes, in whole or in part, at a purchase price equal to 101% of the principal amount thereof plus accrued and unpaid interest to the purchase date.
 
Guarantees Substantially all of Select’s operations are conducted through its subsidiaries. Select’s obligations under the new notes will be fully and unconditionally guaranteed on a senior subordinated basis by all of its wholly owned domestic subsidiaries. For the twelve months ended June 30, 2003, Select’s wholly owned domestic subsidiaries generated 85.2% of Select’s EBITDA, as defined in the Indenture, (or 87.4% on a pro forma basis for the Kessler Acquisition and the issuance of the old notes). At June 30, 2003, those subsidiaries represented approximately 84.0% of Select’s total assets (or 87.3% on a pro forma basis for the Kessler Acquisition and the issuance of the old notes).
 
Ranking The new notes will be subordinated in right of payment to all of Select’s existing and future senior indebtedness, including Select’s obligations in respect of the senior credit facility. The guarantees of the new notes will be subordinated in right of payment to all existing and future senior indebtedness of the subsidiary guarantors, including any borrowings or guarantees by those subsidiaries under the senior credit facility. The new notes will rank equally in right of payment with all of Select’s existing and future senior subordinated indebtedness, including the existing 9 1/2% senior subordinated notes and the old notes, and senior to all of Select’s existing and future subordinated indebtedness. The guarantees of the new notes will rank equally in right of payment with all senior subordinated

11



 

  indebtedness including guarantees of the old notes and senior to all subordinated indebtedness of the subsidiary guarantors.

 
As of June 30, 2003, on a pro forma basis for the Kessler Acquisition and the sale of the old notes, Select (excluding its subsidiaries) would have had approximately $45.7 million of indebtedness to which the new notes would have been subordinated. This amount includes $39.9 million in borrowings and $5.7 million of outstanding letters of credit under Select’s senior credit facility but does not include up to an additional $146.7 million available to Select and its subsidiaries under its senior credit facility. As of June 30, 2003, on a pro forma basis for the Kessler Acquisition and the sale of the old notes, Select’s subsidiary guarantors would have had $50.0 million of guarantor senior debt to which their respective guarantees as to the new notes would be subordinated.
 
As of June 30, 2003, on a pro forma basis for the Kessler Acquisition and the sale of the old notes, Select (excluding its subsidiaries) had $175.0 million of senior subordinated indebtedness with which the new notes would rank equally.
 
As of June 30, 2003, on a pro forma basis for the Kessler Acquisition and the sale of the old notes, the subsidiary guarantors would have had $177.3 million of guarantor senior subordinated debt with which its respective guarantees of the new notes would rank equally and no guarantor subordinated debt with which their respective guarantees would rank senior.
 
Certain covenants The new notes are governed by an indenture with U.S. Bank Trust National Association as trustee. The indenture, among other things, restricts our ability to:
 
• incur additional debt;
 
• incur debt that is junior to our senior debt but senior to the notes;
 
• pay dividends and redeem stock or redeem subordinated debt;
 
• incur or permit to exist certain liens;
 
• enter into agreements that restrict dividends from subsidiaries;
 
• sell assets;
 
• enter into transactions with affiliates;
 
• sell capital stock of subsidiaries;
 
• merge or consolidate; and
 
• enter different lines of business.
 
The covenants listed above are subject to certain exceptions and limitations described in the indenture.

You should refer to the section entitled “Risk factors” for an explanation of certain risks in investing in the new notes.

12



 

Summary consolidated financial and other data

You should read the summary consolidated financial and other data below in conjunction with our consolidated financial statements and the accompanying notes and the unaudited pro forma combined financial information, contained herein. We derived the historical financial data for the years ended December 31, 2000, 2001 and 2002, and as of December 31, 2000, 2001 and 2002 from our audited consolidated financial statements. We derived the historical financial data for the six months ended June 30, 2002 and June 30, 2003, and as of June 30, 2002 and 2003, from our unaudited interim consolidated financial statements. You should also read “Selected consolidated financial and other data” and the accompanying “Management’s discussion and analysis of financial condition and results of operations.” All of these materials are contained later in this offering memorandum. The unaudited pro forma combined statement of operations data for the year ended December 31, 2002 present results of operations before cumulative effects of accounting changes and are pro forma for the Kessler Acquisition and the sale of the old notes as if these transactions had been completed on January 1, 2002. The unaudited pro forma combined statements of operations data for the six months ended June 30, 2003 are pro forma for the Kessler Acquisition and the sale of the old notes as if these transactions had been completed on January 1, 2003. The unaudited pro forma combined balance sheet data as of June 30, 2003 are pro forma for the Kessler Acquisition and the sale of the old notes as if these transactions had been completed on June 30, 2003. You should also read “Unaudited pro forma combined financial information.” The pro forma information shown below as part of the “Summary consolidated financial and other data,” is presented to be consistent with the information presented in “Unaudited pro forma combined financial information.”

13



 

                                                         

Six months ended
Year ended December 31, June 30,


Pro forma Pro forma
(Dollars in thousands) 2000 2001 2002 2002 2002 2003 2003

Consolidated statement of operations data:
                                                       
Net operating revenues
  $ 805,897     $ 958,956     $ 1,126,559     $ 1,354,194     $ 552,192     $ 638,525     $ 757,157  
Operating expenses(a)
    714,227       846,938       999,280       1,192,741       487,950       556,134       667,147  
Depreciation and amortization
    30,401       32,290       25,836       37,701       12,206       14,706       21,146  
   
Income from operations
    61,269       79,728       101,443       123,752       52,036       67,685       68,864  
Loss on early retirement of debt(b)
    6,247       14,223       -       -       -       -       -  
Equity in (income) loss from joint ventures
    -       -       -       889       -       -       (160 )
Interest expense, net
    35,187       29,209       26,614       40,555       13,386       11,706       18,894  
   
Income before minority interests and income taxes
    19,835       36,296       74,829       82,308       38,650       55,979       50,130  
Minority interests(c)
    4,144       3,491       2,022       2,022       1,173       1,537       1,537  
   
Income before income taxes
    15,691       32,805       72,807       80,286       37,477       54,442       48,593  
Income tax provision
    9,979       3,124       28,576       32,431       14,700       21,357       19,132  
   
Net income
    5,712       29,681       44,231       47,855       22,777       33,085       29,461  
Less: Preferred dividends
    8,780       2,513       -       -       -       -       -  
   
Net income (loss) available to common stockholders
  $ (3,068 )   $ 27,168     $ 44,231     $ 47,855     $ 22,777     $ 33,085     $ 29,461  
   
Other financial data:
                                                       
EBITDA(d)
  $ 81,279     $ 94,304     $ 125,257     $ 158,542     $ 63,069     $ 80,854     $ 88,633  
EBITDA as a % of net operating revenue
    10.1%       9.8%       11.1%       11.7%       11.4%       12.7%       11.7%  
Capital expenditures
  $ 22,430     $ 24,011     $ 43,183             $ 17,948     $ 15,206          
Cash flow data:
                                                       
Cash flow provided by operating activities
  $ 22,513     $ 95,770     $ 120,812             $ 50,475     $ 91,272          
Cash flow provided by (used in) investing activities
    14,197       (61,947 )     (54,048 )             (21,787 )     (17,021 )        
Cash flow (used in) financing activities
    (37,616 )     (26,164 )     (21,423 )             (10,629 )     (39,311 )        
 
Balance sheet data (at end of period):
                                                       
Cash and cash equivalents
  $ 3,151     $ 10,703     $ 56,062             $ 28,834     $ 91,351     $ 26,471  
Working capital
    105,567       126,749       130,621               133,019       146,070       109,086  
Total assets
    586,800       650,845       739,059               693,433       737,860       948,862  
Total debt
    302,788       288,423       260,217               272,875       223,943       400,696  
Preferred stock
    129,573       -       -               -       -          
Total stockholders’ equity
    48,498       234,284       286,418               265,028       326,539       326,539  
 
Selected ratios:
                                                       
Ratio of EBITDA to net interest
    2.3 x     3.2 x     4.7 x                                
Ratio of total debt to EBITDA
    3.7 x     3.1 x     2.1 x                                
Ratio of net debt to EBITDA(e)
    3.7 x     2.9 x     1.6 x                                

14



 

Selected operating data

The following table sets forth operating statistics for our specialty hospital and our outpatient rehabilitation segments for each of the periods presented and is not adjusted to reflect the Kessler Acquisition. The data in the table reflects the changes in the number of long term acute care hospitals and outpatient rehabilitation clinics we operate that resulted from acquisitions, start-up activities and closures. The operating statistics reflect data for the period of time these operations were managed by us. Further information on our acquisition activities can be found in “Management’s discussion and analysis of financial condition and results of operations—Results of operations—Select Medical” and the notes to our consolidated financial statements.

                                           

Six months
Year ended December 31, ended June 30,


(Dollars in thousands) 2000 2001 2002 2002 2003

Specialty hospital data:
                                       
Number of hospitals—start of period
    44       54       64       64       72  
 
Number of hospital start-ups
    10       10       8       2       4  
 
Number of hospitals closed
    -       -       -       -       (1 )
   
Number of hospitals—end of period(f)
    54       64       72       66       75  
   
Available licensed beds(g)
    1,982       2,307       2,594       2,383       2,758  
Admissions(h)
    14,210       17,416       21,065       10,230       12,075  
Patient days(i)
    427,448       519,297       619,322       303,811       333,763  
Average length of stay(j)
    30       30       30       30       28  
Occupancy rate(k)
    63%       68%       71%       72%       70%  
Percent patient days—Medicare(l)
    76%       75%       76%       77%       77%  
Adjusted EBITDA(d)
  $ 44,550     $ 57,556     $ 70,891     $ 32,948     $ 56,194  
 
Outpatient rehabilitation data:
                                       
Number of clinics—start of period
    620       636       664       664       679  
 
Number of clinics acquired
    17       32       14       7       33  
 
Number of clinics start-ups
    32       41       49       32       17  
 
Number of clinics closed/sold
    (33 )     (45 )     (48 )     (17 )     (22 )
   
Number of clinics owned—end of period
    636       664       679       686       707  
Number of clinics managed—end of period(m)
    43       53       58       54       30  
   
Total number of clinics
    679       717       737       740       737  
   
Adjusted EBITDA(d)
  $ 65,420     $ 76,127     $ 81,136     $ 44,123     $ 42,894  

(a) Operating expenses include cost of services, general and administrative expenses, and bad debt expenses.

(b)  Reflects the write-off of deferred financing costs that resulted from the refinancing of our senior credit facilities in September 2000. Also reflects the write-off of deferred financing costs and discounts resulting from the repayment of indebtedness with the proceeds from our initial public offering in April 2001 and the 9 1/2% senior subordinated notes offering in June 2001.

(c)  Reflects interests held by other parties in subsidiaries, limited liability companies and limited partnerships owned and controlled by us.

(d)  We define Adjusted EBITDA as net income before interest, income taxes, depreciation and amortization, loss on early retirement of debt, equity in (income) loss from joint ventures and minority interest. Loss on early retirement of debt, equity in (income) loss from joint ventures and minority interest are then deducted from Adjusted EBITDA to derive EBITDA. We believe that the presentation of EBITDA is important to investors because EBITDA is commonly used as an analytical indicator of performance by investors within the healthcare industry. Adjusted EBITDA as presented on a segment basis is used by management to evaluate financial performance and determine resource allocation for each of our operating segments. EBITDA and Adjusted EBITDA are not measures of financial performance under generally accepted accounting

15



 

principles. Items excluded from EBITDA and Adjusted EBITDA are significant components in understanding and assessing financial performance. EBITDA and Adjusted EBITDA should not be considered in isolation or as an alternative to, or substitute for, net income, cash flows generated by operations, investing or financing activities, or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because EBITDA and Adjusted EBITDA are not measurements determined in accordance with generally accepted accounting principles and are thus susceptible to varying calculations, EBITDA and Adjusted EBITDA as presented may not be comparable to other similarly titled measures of other companies. Further information on our acquisition activities can be found in “Management’s discussion and analysis of financial condition and results of operations—Results of operations—Select Medical” and the notes to our consolidated financial statements.

  The following table reconciles EBITDA to net income:

                                                           

Six months ended
Year ended December 31, June 30,


Pro forma Pro forma
(Dollars in thousands) 2000 2001 2002 2002 2002 2003 2003

EBITDA
  $ 81,279     $ 94,304     $ 125,257     $ 158,542     $ 63,069     $ 80,854     $ 88,633  
Less:
                                                       
  Depreciation and amortization     30,401       32,290       25,836       37,701       12,206       14,706       21,146  
  Interest income     (939 )     (507 )     (596 )     (277 )     (207 )     (342 )     (160 )
  Interest expense     36,126       29,716       27,210       40,832       13,593       12,048       19,054  
  Income tax expense     9,979       3,124       28,576       32,431       14,700       21,357       19,132  
   
Net income
  $ 5,712     $ 29,681     $ 44,231     $ 47,855     $ 22,777     $ 33,085     $ 29,461  

The SEC recently adopted rules regarding the use of non-GAAP financial measures, such as EBITDA and Adjusted EBITDA, which we use in this registration statement. Historically, we have defined EBITDA as net income (loss) before interest, income taxes, depreciation and amortization, special charges, loss on early retirement of debt and minority interest, and used this measure to report our consolidated operating results as well as our segment results. We are now referring to this financial measure as Adjusted EBITDA. In order to comply with the new rules, we are now using EBITDA, defined as net income (loss) before interest, income taxes, depreciation and amortization, to report our consolidated operating results. However, SFAS 131 requires us to report our segment results in a manner consistent with management’s internal reporting of operating results to our chief operating decision maker (as defined under SFAS 131) for purposes of evaluating segment performance. Therefore, since we use Adjusted EBITDA to measure performance of our segments for internal reporting purposes, we have used Adjusted EBITDA to report our segment results. The difference between EBITDA and Adjusted EBITDA for the periods presented in this registration statement result from loss on early retirement of debt, equity in (income) loss from joint ventures and minority interests, which are added back to EBITDA in the computation of Adjusted EBITDA.

(e)  Net debt equals total debt less cash and cash equivalents.

(f)   As of June 30, 2003, we owned equity interests in 100% of all of our hospitals except for two hospitals that had a 14% minority owner, three hospitals that had a 3% minority owner and two hospitals that had a 9% minority owner.
 
(g)   Available licensed beds are the number of beds that are licensed with the appropriate state agency and which are readily available for patient use at the end of the period indicated.
 
(h)   Admissions represent the number of patients admitted for treatment.
 
(i)   Patient days represent the total number of days of care provided to patients.
 
(j)   Average length of stay (days) represents the average number of days patients stay in our hospitals per admission, calculated by dividing total patient days by the number of discharges for the period.
 
(k)   We calculate occupancy rate by dividing the average daily number of patients in our hospitals by the weighted average number of available licensed beds over the period indicated.
 
(l)   We calculate percent patient days—medicare by dividing the number of Medicare patient days by the total number of patient days.
 
(m)  Managed clinics are clinics that we operate through long term management arrangements and clinics operated through unconsolidated joint ventures.

16



 

Risk factors

Our business involves a number of risks, some of which are beyond our control. You should carefully consider each of the risks and uncertainties we describe below and all of the other information in this prospectus before making an investment decision. The risks and uncertainties we describe below are not the only ones we face. Additional risks and uncertainties that we do not currently know or that we currently believe to be immaterial may also adversely affect our business.

Risks relating to our business

If there are changes in the rates or methods of government reimbursements for our services our net operating revenues and net income could decline.

The federal government is currently considering substantial changes to various Medicare programs. Some of these proposed changes, whether or not enacted, may affect our operations and financial results. Approximately 40.3% of our net operating revenues for the year ended December 31, 2002 came from the highly regulated federal Medicare program. The methods and rates of Medicare reimbursements may change at any time. Our long term acute care hospitals operate as Medicare-designated long term acute care hospitals. A new Medicare prospective payment system has been established and is being implemented for long term acute care hospitals under which our hospitals are paid a fixed amount for each patient based on the patient’s diagnosis. In this offering memorandum we will refer to this prospective payment system for long term acute care hospitals as “LTCH-PPS”. The new payment system is being phased in over five years during which an increasing percentage of the payment amount for each Medicare patient will be based on the fixed amount and a lesser percentage will be based on the prior reasonable cost-based system subject to caps, although facilities may elect earlier to be paid solely on the basis of the fixed amounts. As of June 30, 2003, forty-nine of our hospitals have converted to LTCH-PPS, and forty-eight of those hospitals elected to accelerate their adoption of LTCH-PPS and be paid solely on the basis of long term care diagnosis-related group payment rates, which we refer to in this offering memorandum as “LTC-DRG”. There are risks associated with transitioning to the new payment system and we are still assessing the potential impact of the LTCH-PPS. Over time, increases in LTC-DRG may not fully reflect increases in our long-term acute care hospital costs. See “Our business— Government regulations— Overview of U.S. and state government reimbursements— Long term acute care hospital Medicare reimbursement.”

Since our acquisition of Kessler, we also operate Medicare-certified inpatient rehabilitation facilities. A Medicare prospective payment system, distinct from the system applicable to long term acute care hospitals, was recently implemented for inpatient rehabilitation facilities, which is referred to as IRF-PPS. Under IRF-PPS, the Kessler hospitals are paid a fixed amount for each patient based upon the condition for which the patient is being treated. Under the IRF-PPS, each patient discharged from an inpatient rehabilitation facility is assigned to a case mix group, or “IRF-CMG,” containing patients with similar clinical problems that are expected to require similar amounts of resources. Over time, increases in IRF-CMG payment rates may not fully reflect increases in our inpatient rehabilitation facility costs. Kessler’s inpatient rehabilitation facilities began to be paid under IRF-PPS on January 1, 2002. See “—Government regulations— Overview of U.S. and state government reimbursements— Inpatient rehabilitation facility Medicare reimbursement.”

17



 

Our outpatient rehabilitation clinics receive payments from the Medicare program under a fee schedule. These payments are currently subject to annual caps that limit the amounts that are paid (including deductible and coinsurance amounts) for outpatient therapy services rendered to any Medicare beneficiary. Initially, the limits were to be effective January 1, 1999. Congress imposed a moratorium on the caps through 2002. The limits were then scheduled to go into effect on July 1, 2003. Following a settlement with a group of plaintiffs seeking to stop the implementation of the therapy caps, CMS delayed the application of these limits until September 1, 2003. The 2003 caps— $1,590 for physical therapy (including speech-language pathology) and $1,590 for occupational therapy— will apply during the balance of 2003 (September 1 through December 31) and, beginning in 2004, inflation-adjusted caps will apply to services provided during the entire calendar year. We believe these therapy caps could have an adverse effect on the revenue we generate from providing outpatient rehabilitation services to Medicare beneficiaries, to the extent that such patients receive services with a cost in excess of the annual caps. For the fiscal year ended December 31, 2002, we received 8.8% of our outpatient rehabilitation net operating revenues from Medicare. See “Our business— Government regulations— Overview of U.S. and state government reimbursements— Outpatient rehabilitation services Medicare reimbursement.”

Implementation of modifications to the admissions policies for Kessler’s inpatient rehabilitation facilities as required in order to achieve compliance with Medicare guidelines may result in a loss of patient volume at these hospitals and, as a result, may reduce our future net operating revenues and profitability.

As of June 30, 2003, five facilities that we acquired from Kessler were certified as Medicare inpatient rehabilitation facilities. In order to be classified as inpatient rehabilitation facilities, each Medicare provider (four of these facilities are certified as one provider) must demonstrate that, during its most recent 12-month cost reporting period, it has served an inpatient population of whom at least 75 percent required intensive rehabilitation services for one or more of ten specified conditions. Recently, the Centers for Medicare & Medicaid Services proposed changes to this classification standard which requires the provider to demonstrate that, during the most recent, consecutive and appropriate 12-month period, it has served an inpatient population of whom at least 65 percent required intensive rehabilitation services for one or more of 12 specified conditions. In the past, the classification standard has been enforced by Medicare contractors inconsistently, if at all, and the Kessler inpatient rehabilitation facilities may not have been operated in full compliance with the standard. In its recent proposed rule, the Centers for Medicare & Medicaid Services indicated that it will instruct its contractors to begin enforcing the revised classification standard in cost reporting periods beginning on or after the anticipated January 1, 2004 effective date of the final rule. In order to achieve compliance with the classification standard, as it may be amended, it may be necessary for us to implement, during cost reporting periods beginning on or after January 1, 2004, more restrictive admissions policies at the Kessler facilities for patients not falling within the specified conditions. Such policies may result in decreased patient volumes, which could have a negative effect on the financial performance of these facilities. The agency has not indicated that its enforcement efforts, which are anticipated to begin in cost reporting periods beginning on or after January 1, 2005, will be retrospective; in case they are, the selling stockholder has agreed to reimburse us for amounts required to be repaid if Kessler is found to have been non-compliant with the applicable classification standard during periods prior to the Kessler Acquisition. See “—Government regulations— Overview of U.S. and state government reimbursements— Inpatient rehabilitation facility Medicare reimbursement.”

18



 

If our hospitals fail to maintain their certification as long term acute care hospitals or fail to qualify as hospitals separate from their host hospitals, our profitability may decline.

As of June 30, 2003, 71 of our 75 hospitals were certified as Medicare long term acute care hospitals, and the remaining four were in the process of becoming certified as Medicare long term acute care hospitals. If our hospitals fail to meet or maintain the standards for certification as long term acute care hospitals, such as average minimum length of patient stay, they will receive payments under the prospective payment system applicable to general acute care hospitals rather than payment under the system applicable to long term acute care hospitals. Payments at rates applicable to general acute care hospitals would likely result in our hospitals receiving less Medicare reimbursement than they currently receive for their patient services. Moreover, nearly all of our hospitals are subject to additional Medicare criteria because they operate as separate hospitals located in space leased from, and located in, a general acute care hospital, known as a host hospital. This is known as a “hospital within a hospital” model. These additional criteria include limitations on services purchased from the host hospital and other requirements concerning separateness from the host hospital. If several of our hospitals were to be subject to payment as general acute care hospitals or fail to comply with the separateness requirements, our profit margins would likely decrease. See “Our business— Government regulations— Overview of U.S. and state government reimbursements— Long term acute care hospital Medicare reimbursement.”

We conduct business in a heavily regulated industry, and changes in regulations or violations of regulations may result in increased costs or sanctions that reduce our net operating revenues and profitability.

The healthcare industry is subject to extensive federal, state and local laws and regulations relating to:

  • facility and professional licensure, including certificates of need;

  •  conduct of operations, including financial relationships among healthcare providers, Medicare fraud and abuse, and physician self-referral;

  • addition of facilities and services; and
 
  • payment for services.

Recently, there have been heightened coordinated civil and criminal enforcement efforts by both federal and state government agencies relating to the healthcare industry, including the specialty hospital and outpatient rehabilitation clinic businesses. The ongoing investigations relate to, among other things, various referral practices, cost reporting, billing practices, physician ownership and joint ventures involving hospitals. In the future, different interpretations or enforcement of these laws and regulations could subject our current practices to allegations of impropriety or illegality or could require us to make changes in our facilities, equipment, personnel, services and capital expenditure programs, and increase our operating expenses. If we fail to comply with these extensive laws and government regulations, we could become ineligible to receive government program reimbursement, suffer civil or criminal penalties or be required to make significant changes to our operations. In addition, we could be forced to expend considerable resources responding to an investigation or other enforcement action under these laws or regulations. See “Our business— Government regulations.”

19



 

Integrating Kessler into our company structure may strain our resources and prove to be difficult.

The expansion of our business and operations resulting from the Kessler Acquisition may strain our administrative, operational and financial resources and will result in our incurrence of additional indebtedness. The continued integration of Kessler into our business will require substantial time, effort, attention and dedication of management resources and may distract our management from our existing business in unpredictable ways and may take longer than anticipated. The integration process could create a number of potential challenges and adverse consequences for us, including the difficulty and expense of integrating acquired personnel into our existing business, the difficulty and expense of integrating Kessler’s billing and information systems with ours, the possible unexpected loss of key employees, customers or suppliers, a possible loss of net operating revenues or an increase in operating or other costs and the assumption of liabilities and exposure to unforeseen liabilities of Kessler. These types of challenges and uncertainties could have a material adverse effect on our business, financial condition and results of operations. We may not be able to manage the combined operations and assets effectively or realize all or any of the anticipated benefits of the Kessler Acquisition.

Future acquisitions may use significant resources, may be unsuccessful and could expose us to unforeseen liabilities.

As part of our growth strategy, we intend to pursue acquisitions of specialty hospitals and outpatient rehabilitation clinics. Acquisitions may involve significant cash expenditures, debt incurrence, additional operating losses, dilutive issuances of equity securities and expenses that could have a material adverse effect on our financial condition and results of operations. Acquisitions involve numerous risks, including:

  • the difficulty and expense of integrating acquired personnel into our business;
 
  • diversion of management’s time from existing operations;
 
  • potential loss of key employees or customers of acquired companies; and

  •  assumption of the liabilities and exposure to unforeseen liabilities of acquired companies, including liabilities for failure to comply with healthcare regulations.

We cannot assure you that we will succeed in obtaining financing for acquisitions at a reasonable cost, or that such financing will not contain restrictive covenants that limit our operating flexibility. We also may be unable to operate acquired hospitals and outpatient rehabilitation clinics profitably or succeed in achieving improvements in their financial performance.

Our indebtedness may limit cash flow available to invest in the ongoing needs of our business to generate future cash flow, which could prevent us from fulfilling our obligations under the notes.

We have a significant amount of indebtedness. The following chart sets forth important credit information on a pro forma basis after giving effect to the Kessler Acquisition and the offering of the old notes as of June 30, 2003, or at the beginning of the period, specified below:

         

(Dollars in millions) As of June 30, 2003

Total indebtedness
  $ 400.7  
Total stockholders’ equity
    326.5  

20



 

         

Six
months ended
June 30, 2003

Ratio of earnings to fixed charges
    2.4 x

As of June 30, 2003, we had approximately $146.7 million of availability under our senior credit facility, subject to specific requirements, including compliance with financial covenants.

Our indebtedness could have important consequences to you. For example, it could:

  •  require us to dedicate a substantial portion of our cash flow from operations to payments on our indebtedness, reducing the availability of our cash flow to fund working capital, capital expenditures, research and development efforts and other general corporate purposes;
 
  •  increase our vulnerability to adverse general economic or industry conditions;
 
  •  limit our flexibility in planning for, or reacting to, changes in our business or the industry in which we operate;
 
  •  prevent us from raising the funds necessary to repurchase all notes tendered to us upon the occurrence of specific changes of control in our ownership, which failure to repurchase would constitute a default under the indenture governing our notes; or
 
  •  place us at a competitive disadvantage compared to our competitors that have less indebtedness.

See “Capitalization,” “Summary consolidated financial and other data,” “Selected consolidated financial and other data,” and “Description of other indebtedness.”

Despite our level of indebtedness, we and our subsidiaries will be able to incur more debt. This could further exacerbate the risks described above.

We and our subsidiaries may be able to incur additional indebtedness in the future. Although the indenture governing the notes contains restrictions on the incurrence of additional indebtedness, these restrictions are subject to a number of qualifications and exceptions, and the indebtedness incurred in compliance with these restrictions could be substantial. Also, these restrictions do not prevent us or our subsidiaries from incurring obligations that do not constitute indebtedness. As of June 30, 2003, we have approximately $146.7 million of availability under our senior credit facility, subject to specific requirements, including compliance with financial covenants, all of which would be senior to the new notes. In addition, as of June 30, 2003 we also have outstanding $175.0 million principal amount of our 9 1/2% senior subordinated notes and $2.3 million of other senior subordinated indebtedness which will rank equally with the new notes. To the extent new debt is added to our and our subsidiaries’ currently anticipated debt levels, the substantial leverage risks described above would increase. See “Description of notes” and “Description of other indebtedness.”

21



 

To service our indebtedness, we will require a significant amount of cash. Our ability to generate cash depends on many factors beyond our control, including possible changes in government reimbursement rates or methods. If we cannot generate the required cash, we may not be able to make the required payments under the new notes.

Our ability to make payments on our indebtedness, including the new notes, and to fund planned capital expenditures will depend on our ability to generate cash in the future. Our future financial results would be subject to substantial fluctuations upon a significant change in government reimbursement rates or methods. We cannot assure you that our business will generate sufficient cash flow from operations, or that future borrowings will be available to us in an amount sufficient to enable us to pay our indebtedness, including the new notes, or to fund our other liquidity needs. Our inability to pay our debts would require us to pursue one or more alternative strategies, such as selling assets, refinancing or restructuring our indebtedness or selling equity capital. However, we cannot assure you that any alternative strategies will be feasible at the time or prove adequate. Also, some alternative strategies would require the prior consent of our senior secured lenders, which we may not be able to obtain. See “Management’s discussion and analysis of financial condition and results of operations” and “Description of other indebtedness.”

Future cost containment initiatives undertaken by private third party payors may limit our future net operating revenues and profitability.

Initiatives undertaken by major insurers and managed care companies to contain healthcare costs affect the profitability of our specialty hospitals and outpatient rehabilitation clinics. These payors attempt to control healthcare costs by contracting with hospitals and other healthcare providers to obtain services on a discounted basis. We believe that this trend may continue and may limit reimbursements for healthcare services. If insurers or managed care companies from whom we receive substantial payments were to reduce the amounts they pay for services, our profit margins may decline, or we may lose patients if we choose not to renew our contracts with these insurers at lower rates.

If we fail to cultivate new or maintain established relationships with the physicians in our markets, our net operating revenues may decrease.

Our success is, in part, dependent upon the admissions and referral practices of the physicians in the communities our hospitals and our outpatient rehabilitation clinics serve, and our ability to maintain good relations with these physicians. Physicians referring patients to our hospitals and clinics are generally not our employees and, in many of the markets that we serve, most physicians have admitting privileges at other hospitals and are free to refer their patients to other providers. If we are unable to successfully cultivate and maintain strong relationships with these physicians, our hospitals’ admissions and clinics’ businesses may decrease, and our net operating revenues may decline.

Shortages in qualified nurses could increase our operating costs significantly.

Our specialty hospitals are highly dependent on nurses for patient care. The availability of qualified nurses has declined in recent years, and the salaries for nurses have risen accordingly. We cannot assure you we will be able to attract and retain qualified nurses in the future. Additionally, the cost of attracting and retaining nurses may be higher than we anticipate, and as a result, our profitability could decline.

22



 

Competition may limit our ability to acquire hospitals and clinics and adversely affect our growth.

We have historically faced limited competition in acquiring specialty hospitals and outpatient rehabilitation clinics, but we may face heightened competition in the future. Our competitors may acquire or seek to acquire many of the hospitals and clinics that would be suitable candidates for us. This could limit our ability to grow by acquisitions or make our cost of acquisitions higher and less profitable.

If we fail to compete effectively with other hospitals, clinics and healthcare providers, our net operating revenues and profitability may decline.

The healthcare business is highly competitive, and we compete with other hospitals, rehabilitation clinics and other healthcare providers for patients. If we are unable to compete effectively in the specialty hospital and outpatient rehabilitation businesses, our net operating revenues and profitability may decline. Many of our specialty hospitals operate in geographic areas where we compete with at least one other hospital that provides similar services. Our outpatient rehabilitation clinics face competition from a variety of local and national outpatient rehabilitation providers. Other outpatient rehabilitation clinics in markets we serve may have greater name recognition and longer operating histories than our clinics. The managers of these clinics may also have stronger relationships with physicians in their communities, which could give them a competitive advantage for patient referrals.

Significant legal actions as well as the cost and possible lack of available insurance could subject us to substantial uninsured liabilities.

In recent years, physicians, hospitals and other healthcare providers have become subject to an increasing number of legal actions alleging malpractice, product liability or related legal theories. Many of these actions involve large claims and significant defense costs. We are also subject to lawsuits under a federal whistleblower statute designed to combat fraud and abuse in the healthcare industry. These lawsuits can involve significant monetary damages and award bounties to private plaintiffs who successfully bring the suits.

We maintain professional malpractice liability insurance and general liability insurance coverage. As a result of unfavorable pricing and availability trends in the professional liability insurance market and the insurance market in general, the cost and risk sharing components of professional liability coverage has changed dramatically. Many insurance underwriters have become more selective in the insurance limits and types of coverage they will provide as a result of the September 11, 2001 terrorist attacks, rising settlement costs and the significant failures of some nationally known insurance underwriters. In some instances, insurance underwriters will no longer issue new policies in certain states that have a history of high medical malpractice awards. As a result, we experienced substantial changes in our medical and professional malpractice insurance program that we renewed on December 31, 2002. Among other things, in order to obtain malpractice insurance at a reasonable cost, we were required to assume substantial self-insured retentions for our professional liability claims. A self-insured retention is a minimum amount of liability and legal fees that we must pay for each claim. We have engaged an actuary to assist us in determining the value of the losses that may occur within this self-insured retention level. Pursuant to the requirements under our insurance agreements, we will post an additional letter of credit equal to the estimated losses that we will assume for the 2003 policy year. Because of the high retention levels, we cannot predict with certainty the actual amount of the losses we will assume and pay. To the extent that

23



 

subsequent claims information varies from loss estimates, the liabilities will be adjusted to reflect current loss data. We believe that our current insurance program is adequate in amount and coverage. However, there can be no assurance that in the future such insurance will be available at a reasonable price or that we will not have to further increase our levels of self-insurance. In addition, our insurance coverage does not cover punitive damages and may not cover all claims against us. See “Our business— Government regulations— Other healthcare regulations,” and “Management’s discussion and analysis of financial condition and results of operations— Capital resources and liquidity— Commitments and contingencies.”

Risks relating to the offering

Your right to receive payments on the new notes— like the old notes, will be junior to our existing senior indebtedness and the existing senior indebtedness of the subsidiary guarantors and possibly all of our and their future indebtedness. Further, claims of creditors of our non-guarantor subsidiaries will generally have priority with respect to the assets of those subsidiaries over your claims.

The new notes— like the old notes, and the subsidiary guarantees will be subordinated to the prior payment in full of our and the subsidiary guarantors’ respective current and future senior indebtedness to the extent set forth in the indenture. In addition, the new notes and subsidiary guarantees will rank equally with our 9 1/2% senior subordinated notes, any old notes not exchanged, and the guarantees by our subsidiaries of those notes and any other future and existing senior subordinated indebtedness. As of June 30, 2003, on a pro forma basis for the Kessler Acquisition and the sale of the old notes, we would have had approximately $50.0 million of indebtedness to which the new notes would have been subordinated and $177.3 million of indebtedness to which the new notes would have had equal priority. Because of the subordination provisions of the new notes, in the event of the bankruptcy, liquidation or dissolution of our company or any guarantor, our assets or the assets of the guarantors would be available to pay obligations under the new notes and our other senior subordinated obligations only after all payments had been made on our senior indebtedness or the senior indebtedness of our subsidiary guarantors. Sufficient assets may not remain after all these payments have been made to make any payments on the new notes and our other senior subordinated obligations, including payments of interest when due. In addition, all payments on, any old notes not exchanged, the new notes and the guarantees will be prohibited in the event of a payment default on our senior indebtedness (including borrowings under the senior credit facilities) and, for limited periods, upon the occurrence of other defaults under the senior credit facilities.

We conduct all of our business through our subsidiaries. The aggregate net operating revenues and EBITDA, as defined in the Indenture, for the six months ended June 30, 2003, on a pro forma basis for the Kessler Acquisition and the sale of the old notes, of our subsidiaries that are not guaranteeing the new notes were $105.6 million and $12.6 million, respectively, and at June 30, 2003, those subsidiaries had total assets of $120.7 million. Claims of creditors of the non-guarantor subsidiaries, including trade creditors, secured creditors and unsecured creditors, and claims of preferred stockholders (if any) of the non-guarantor subsidiaries, will generally have priority with respect to their assets and earnings over the claims of creditors of our company, including holders of the new notes, even if the obligations of the subsidiaries do not constitute senior indebtedness. See “Description of notes—Ranking” and “Description of notes—Certain covenants—Limitation on indebtedness.” See also “Description of notes—

24



 

Subsidiary guarantees” and Note 19 to Select’s audited consolidated financial statements included herein.

The new notes— like the old notes, will not be secured by our assets nor those of our subsidiaries, and the lenders under the senior credit facility will be entitled to remedies available to a secured lender, which gives them priority over the new note holders to collect amounts due to them.

In addition to being subordinated to all of our existing and future senior indebtedness and pari passu with our 9 1/2% senior subordinated notes and any old notes not exchanged, the new notes and the subsidiary guarantees will not be secured by any of our assets. Our obligations under the senior credit facility are secured by, among other things, a first priority pledge of all of the capital stock of our wholly-owned domestic subsidiaries, mortgages upon substantially all of the real property owned by us in the U.S. and by substantially all of the assets of our company and each of our existing and subsequently acquired or organized material domestic (and, to the extent no adverse tax consequences will result, foreign) subsidiaries. If we become insolvent or are liquidated, or if payment under the senior credit facility or in respect of any other secured senior indebtedness is accelerated, the lenders under the senior credit facility or holders of other secured senior indebtedness will be entitled to exercise the remedies available to a secured lender under applicable law (in addition to any remedies that may be available under documents pertaining to the senior credit facility or the other senior debt). Upon the occurrence of any default under the senior credit facility (and even without accelerating the indebtedness under the senior credit facility), the lenders may be able to prohibit the payment of the new notes and guarantees either by limiting our ability to access our cash flow or under the subordination provisions contained in the indenture governing the new notes. In addition, we and or the subsidiary guarantors may incur additional secured senior indebtedness, the holders of which will also be entitled to the remedies available to a secured lender. See “Description of other indebtedness” and “Description of notes.”

Restrictions imposed by our senior credit facility, the indentures governing our 9 1/2% senior subordinated notes and these notes limit our ability to engage in or enter into business, operating and financing arrangements, which could prevent us from taking advantage of potentially profitable business opportunities.

The operating and financial restrictions and covenants in our debt instruments, including the senior credit facility, our 9 1/2% senior subordinated notes, any old notes not exchanged and the new notes, may affect adversely our ability to finance our future operations or capital needs or engage in other business activities that may be in our interest. For example, our senior credit facility restricts our ability to, among other things:

          • incur additional debt;

          • pay dividends;

          • make certain investments;

          • incur or permit to exist certain liens;

          • enter into transactions with affiliates;

          • merge, consolidate or amalgamate with another company;

          • transfer or otherwise dispose of assets;

25



 

          • redeem subordinated debt;

          • incur capital expenditures; and

          • incur contingent obligations.

The indenture governing our 9 1/2% senior subordinated notes includes, and the old notes and the new notes offered hereby will include similar restrictions. See “Description of notes.” Our senior credit facility also requires us to comply with certain financial covenants which become more restrictive over time. Our ability to comply with these ratios may be affected by events beyond our control. A breach of any of these covenants or our inability to comply with the required financial ratios could result in a default under our senior credit facility. In the event of any default under our senior credit facility, the lenders under our senior credit facility could elect to declare all borrowings outstanding together with accrued and unpaid interest and other fees, to be due and payable, to require us to apply all of our available cash to repay these borrowings or to prevent us from making debt service payments on these notes, any of which would be an event of default under these notes. See “Description of notes” and “Description of other indebtedness.”

We may not have the ability to raise the funds necessary to finance the change of control offer required by the indentures governing the old notes and the new notes and our 9 1/2% senior subordinated notes, which would violate the terms of any old notes not exchanged, the new notes and our 9 1/2% senior subordinated notes.

Upon the occurrence of a change of control, we will be required to offer to repurchase all of our 9 1/2% senior subordinated notes, any old notes not exchanged, and all of these new notes. We cannot assure you that there will be sufficient funds available for us to make any required repurchases of these notes, upon a change of control. In addition, our senior credit facility will prohibit us from purchasing any notes and provide that the occurrence of a change of control constitutes a default. If we do not repay all borrowings under our senior credit facility or obtain a consent of our lenders under our senior credit facility to repurchase these notes, we will be prohibited from purchasing the old notes or the new notes. Our failure to purchase tendered notes would constitute a default under the indenture governing old notes not exchanged and the new notes, which, in turn, would constitute a default under our senior credit facility. See “Description of notes—Change of control.”

A subsidiary guarantee could be voided if it constitutes a fraudulent transfer under U.S. bankruptcy laws or comparable state laws, which could result in the holders of the new notes not being able to rely on that subsidiary guarantor to satisfy claims.

Our obligations under the new notes will be guaranteed on a general unsecured senior subordinated basis by the subsidiary guarantors. Under U.S. bankruptcy law and comparable provisions of state fraudulent transfer laws, a guarantee can be voided, or claims under a guarantee may be subordinated to all other debts of that guarantor if, among other things, the guarantor, at the time it incurred the indebtedness evidenced by its guarantee:

  •  intended to hinder, delay or defraud any present or future creditor or received less than reasonably equivalent value or fair consideration for the incurrence of the guarantee; and

26



 

  •  the guarantor:

  was insolvent or rendered insolvent by reason of the incurrence;
 
  was engaged in a business or transaction for which the guarantor’s remaining assets constituted unreasonably small capital; or
 
  intended to incur, or believed that it would incur, debts beyond its ability to pay those debts as they mature.

In addition, any payment by that guarantor under a guarantee could be voided and required to be returned to the guarantor or to a fund for the benefit of the creditors of the guarantor.

The measures of insolvency for purposes of fraudulent transfer laws will vary depending upon the governing law. Generally, a guarantor would be considered insolvent if:

  •  the sum of its debts, including contingent liabilities, was greater than the fair saleable value of all of its assets;
 
  •  the present fair salable value of its assets was less than the amount that would be required to pay its probable liability on its existing debts, including contingent liabilities, as they become absolute and mature; or
 
  •  it could not pay its debts as they become due.

There is no public trading market for the new notes and an active trading market may not develop for the new notes.

The old notes are currently eligible for trading in the PORTAL Market, a screen-based market operated by the National Association of Securities Dealers. The PORTAL market is limited to qualified institutional investors as defined by Rule 144A of the Securities Act. The new notes are new securities for which there is no established trading market. We do not intend to apply for listing or quotation of the notes on any securities exchange or stock market.

J.P. Morgan Securities Inc., Merrill Lynch, Pierce, Fenner & Smith, Inc., Wachovia Capital Markets, SG Cowen, CIBC World Markets Corp., Fleet Securities, Inc. and Jefferies & Company, Inc. acted as initial purchasers in connection with the offer and sale of the old notes. The initial purchasers have informed us that they intend to make a market in the notes. However, these initial purchasers may cease their market-making at any time. In addition, the liquidity of the trading market in the new notes, and the market price quoted for the new notes, may be adversely affected by changes in the overall market for high yield securities and by changes in our financial performance or prospects or in the prospects for companies in our industry generally. As a result, we cannot assure you that an active trading market will develop for the new notes.

Failure to tender your old notes for new notes could limit your ability to resell the old notes.

The old notes were not registered under the Securities Act or under the securities laws of any state and may not be resold, offered for resale or otherwise transferred unless they are subsequently registered or resold under an exemption from the registration requirements of the Securities Act and applicable state securities laws. If you do not exchange your old notes for new notes under the exchange offer, you will not be able to resell, offer to resell or otherwise transfer the old notes unless they are registered under the Securities Act or unless you resell them, offer to resell or otherwise transfer them under an exemption from the

27



 

registration requirements of, or in a transaction not subject to, the Securities Act. In addition, we will no longer be under an obligation to register the old notes under the Securities Act except in the limited circumstances provided under the registration rights agreement. In addition, if you want to exchange your old notes in the exchange offer for the purpose of participating in a distribution of the new notes, you may be deemed to have received restricted securities, and, if so, will be required to comply with the registration and prospectus delivery requirements of the Securities Act in connection with any resale transaction.

Risk relating to our structure

We have a holding company structure and will depend on distributions from our operating subsidiaries to pay these new notes. Contractual or legal restrictions applicable to our subsidiaries could limit distributions from them.

We are a holding company and derive all of our operating income from, and hold substantially all of our assets through, our subsidiaries. The effect of this structure is that we will depend on the earnings of our subsidiaries, and the payment or other distributions to us of these earnings, to meet our obligations under our senior credit facility, our 9 1/2% senior subordinated notes, any old notes not exchanged and these new notes. Provisions of law, like those requiring that dividends be paid only out of surplus, and provisions of our senior indebtedness and the indenture governing our 9 1/2% senior subordinated notes limit the ability of our subsidiaries to make payments or other distributions to us. Our subsidiaries also could agree to other contractual restrictions on their ability to make distributions. See “Description of other indebtedness.”

A substantial number of shares of our common stock are owned by a limited number of persons, and their interests may conflict with your interests.

Affiliates of Welsh, Carson, Anderson & Stowe VII, L.P., GTCR Golder Rauner, LLC, Thoma Cressey Equity Partners, and our directors and executive officers together own a substantial portion of our outstanding common stock. By virtue of this stock ownership, such persons have the power to significantly influence our affairs and are able to influence the outcome of matters required to be submitted to stockholders for approval, including the election of directors and the amendment of our certificate of incorporation or bylaws. We cannot assure you that such persons will not exercise their influence over us in a manner detrimental to your interests.

If provisions in our corporate documents and Delaware law delay or prevent a change in control of our company, we may be unable to consummate a transaction that our stockholders consider favorable.

Our certificate of incorporation, by-laws and shareholder rights plan may discourage, delay, or prevent a merger or acquisition involving us that our stockholders may consider favorable by:

  •  authorizing the issuance of preferred stock, the terms of which may be determined at the sole discretion of the board of directors;
 
  •  providing for a classified board of directors with staggered three-year terms;

28



 

  •  establishing advance notice requirements for nominations for election to the board of directors or for proposing matters that can be acted on by stockholders at meetings; and
 
  •  deterring hostile takeover attempts by preventing potential acquirors from acquiring beneficial ownership of 15% or more of our common stock without our consent.

29



 

Use of proceeds

We will not receive any proceeds from the exchange offer. In consideration for issuing the new notes, we will receive in exchange old notes of like principal amount, the terms of which are identical in all material respects to the new notes. The old notes surrendered in exchange for new notes will be retired and canceled and cannot be reissued. Accordingly, issuance of the new notes will not result in any increase in our indebtedness. We have agreed to bear the expenses of the exchange offer. No underwriter is being used in connection with the exchange offer.

The net proceeds from the sale of the old notes was approximately $169.4 million, after deducting initial purchaser discounts, and estimated fees and expenses of the offering. We used the net proceeds from this offering of the old notes to fund a portion of the purchase price of the Kessler Acquisition.

The following table sets forth the sources and uses of funds in connection with the closing of the Kessler Acquisition:

           

Sources of funds: (Dollars in thousands)

7 1/2% senior subordinated notes due 2013
  $ 175,000  
Existing cash
    64,027  
     
 
 
Total sources
  $ 239,027  

           

Uses of funds: (Dollars in thousands)

Kessler cash purchase price(a)
  $ 228,318  
Acquisition costs paid at closing
    5,109  
Financing and related fees
    5,600  
     
 
 
Total uses
  $ 239,027  

(a)  The purchase price is subject to a post-closing adjustment based upon the amount of working capital at closing. In addition, we have accrued $11.5 million for transaction related costs that are expected to be funded post-closing.

30



 

Capitalization

The following table sets forth (i) our capitalization as of June 30, 2003 on an actual basis and (ii) our capitalization on a pro forma basis to give effect to the Kessler Acquisition and the sale of the old notes as if these transactions had been completed on June 30, 2003.

                   

As of June 30, 2003

(Dollars in thousands) Actual Pro forma

Cash and cash equivalents
  $ 91,351     $ 26,471 (a)
   
Revolving credit facility
    - (b)     - (a)
Existing term loans
    39,919       39,919  
Other senior debt
    2,651       4,404 (c)
   
 
Total senior debt
    42,570       44,323  
9 1/2% senior subordinated notes due 2009
    175,000       175,000  
7 1/2% senior subordinated notes due 2013
    -       175,000  
Other debt
    6,373       6,373  
   
 
Total debt
    223,943       400,696  
Total stockholders’ equity
    326,539       326,539  
   
 
Total capitalization
  $ 550,482     $ 727,235  

(a)  The unaudited pro forma capitalization information above is presented on a pro forma basis to give effect to the Kessler Acquisition and the offering of the old notes as if these transactions had been completed on June 30, 2003, consistent with the information presented in “Unaudited pro forma combined financial information.”

(b) As of June 30, 2003, we had $146.7 million of availability under our revolving credit facility, subject to certain limitations.

(c)  Includes approximately $1.7 million of debt, issued by Kessler in connection with past acquisitions.

31



 

Unaudited pro forma combined financial information

Our historical consolidated financial statements and the historical financial statements of Kessler Rehabilitation Corporation are included elsewhere in this prospectus. The unaudited pro forma combined financial information presented herein should be read together with those financial statements and related notes and “Management’s discussion and analysis of financial condition and results of operations.”

We prepared the unaudited pro forma combined financial information to reflect:

•  The acquisition of Kessler Rehabilitation Corporation; and
 
•  The sale of the old notes described in this prospectus

as if such events had occurred on January 1, 2002 and January 1, 2003 for the pro forma combined statements of operations for the year ended December 31, 2002, and the six months ended June 30, 2003, respectively. We prepared the pro forma combined balance sheet as if the events had occurred on June 30, 2003.

We adjusted our historical consolidated statements of operations for the year ended December 31, 2002 and the six months ended June 30, 2003 to arrive at the unaudited pro forma combined statements of operations for the year ended December 31, 2002 and the six months ended June 30, 2003.

No adjustments have been made with respect to a number of small acquisitions made during 2002 and 2003 since these acquisitions are not material to the pro forma results.

The acquisition of Kessler Rehabilitation Corporation for $228.3 million in cash, the assumption of $1.7 million of indebtedness and estimated acquisition and reorganization costs of $16.6 million has been accounted for using the purchase method of accounting. Actual acquisition costs may differ from this estimate based upon our final integration plans. The purchase price was allocated to the fair value of Kessler Rehabilitation Corporation’s assets and liabilities based on preliminary valuation estimates. The excess purchase price was allocated to goodwill. Under generally accepted accounting principles, goodwill is not amortized but is reviewed for impairment annually. A formal valuation study is currently being performed to identify and value all tangible and identifiable intangible assets. Thus, the actual acquisition costs and the allocation of these costs may differ from these pro forma financial statements. If our non-goodwill assets are written up to a higher fair value in connection with the valuation study, our expenses in the future will be higher as a result of increased depreciation or amortization of our assets.

Certain information normally included in financial statements prepared in accordance with generally accepted accounting principles has been omitted pursuant to the rules and regulations of the Securities and Exchange Commission.

The pro forma combined statements of operations are not necessarily indicative of results that would have occurred had the acquisition been completed on January 1, 2002 and January 1, 2003 and should not be construed as being representative of future results of operations.

32



 

Unaudited pro forma combined balance sheet

                                   

As of June 30, 2003

Select Kessler
(Dollars in thousands) historical historical Adjustments Pro forma

Current assets:
                               
 
Cash and cash equivalents
  $ 91,351     $ 20,537     $ (85,417 ) (a)(b)(g)   $ 26,471  
 
Accounts receivable, net
    199,723       45,003       -       244,726  
 
Current deferred tax asset
    42,058       14,005       (413 )(b)     55,650  
 
Other current assets
    17,265       4,595       -       21,860  

Total current assets
    350,397       84,140       (85,830 )     348,707  
Property and equipment, net
    112,421       59,334       5,269 (i)     177,024  
Goodwill
    211,348       23,005       83,639 (c)     317,992  
Trademark
    37,875       -       -       37,875  
Intangible assets
    935       -       23,956 (j)     24,891  
Prepaid pension expense
    -       15,526       (15,526 ) (d)     -  
Non-current deferred tax asset
    7,262       2,100       5,795 (d)(e)(f)     15,157  
Other assets
    17,622       4,581       5,013 (e)(f)(g)     27,216  

Total assets
  $ 737,860     $ 188,686     $ 22,316     $ 948,862  

Current liabilities:
                               
 
Bank overdrafts
  $ 6,765     $ -     $ -     $ 6,765  
 
Current portion of long-term debt and notes payable
    22,176       3,795       (2,750 ) (f)     23,221  
 
Accounts payable and accrued expenses
    135,031       22,811       10,479 (b)(h)     168,321  
 
Income taxes payable
    8,917       1,109       (3,921 ) (b)(e)(k)     6,105  
 
Due to third party payors
    31,438       3,771       -       35,209  

Total current liabilities
    204,327       31,486       3,808       239,621  
Long-term debt, net of current portion
    201,767       35,458       140,250 (f)(g)     377,475  
Other long-term liabilities
    -       1,260       (1,260 ) (b)(f)     -  

Total liabilities
    406,094       68,204       142,798       617,096  
Minority interest in consolidated subsidiary companies
    5,227       -       -       5,227  
Stockholders’ equity:
                               
 
Common stock
    481       2       (2 )(l)     481  
 
Capital in excess of par
    238,685       114,430       (114,430 ) (l)     238,685  
 
Retained earnings
    83,240       6,815       (6,815 ) (l)     83,240  
 
Accumulated other comprehensive income (loss)
    4,133       (765 )     765 (l)     4,133  

Total stockholders’ equity
    326,539       120,482       (120,482 )     326,539  
Total liabilities and stockholders’ equity
  $ 737,860     $ 188,686     $ 22,316     $ 948,862  

33



 

Unaudited pro forma combined statement of operations

                                 

Six months ended June 30, 2003

Select Kessler
(Dollars in thousands except per share data) historical historical Adjustments Pro forma

Net operating revenues
  $ 638,525     $ 118,632     $ -     $ 757,157  
   
Operating expenses
    556,134       111,013       -       667,147  
Depreciation and amortization
    14,706       4,729       1,711 (j)     21,146  
   
Total costs and expenses
    570,840       115,742       1,711       688,293  
   
Income from operations
    67,685       2,890       (1,711 )     68,864  
Equity in income from joint ventures
    -       (8 )     (152 )(e)     (160 )
Interest expense, net
    11,706       1,265       5,923 (f)(g)     18,894  
   
Income before minority interests and income tax expense
    55,979       1,633       (7,482 )     50,130  
Minority interests
    1,537       -       -       1,537  
   
Income before income taxes
    54,442       1,633       (7,482 )     48,593  
Income tax expense
    21,357       677       (2,902 ) (m)     19,132  
   
Net income
  $ 33,085     $ 956     $ (4,580 )   $ 29,461  
   
 
Basic income per common share
  $ 0.70                     $ 0.62  
Weighed average basic common shares outstanding (in thousands)
    47,339                       47,339  
Diluted income per common share
  $ 0.66                     $ 0.59  
Weighted average diluted common shares outstanding (in thousands)
    50,002                       50,002  

34



 

Unaudited pro forma combined statement of operations

                                 

Year ended December 31, 2002

Select Kessler
(Dollars in thousands except per share data) historical historical Adjustments Pro forma

Net operating revenues
  $ 1,126,559     $ 227,635     $ -     $ 1,354,194  
   
Operating expenses
    999,280       193,461       -       1,192,741  
Depreciation and amortization
    25,836       8,443       3,422(j )     37,701  
   
Total costs and expenses
    1,025,116       201,904       3,422       1,230,442  
   
Income from operations
    101,443       25,731       (3,422 )     123,752  
Equity in losses from joint ventures
    -       1,636       (747 )(e)     889  
Interest expense, net
    26,614       2,181       11,760 (f)(g)     40,555  
   
Income before minority interests, income tax expense and cumulative effect of accounting change
    74,829       21,914       (14,435 )     82,308  
Minority interests
    2,022       -       -       2,022  
   
Income before income taxes and cumulative effect of accounting change
    72,807       21,914       (14,435 )     80,286  
Income tax expense
    28,576       9,401       (5,546 )(m)     32,431  
   
Income before cumulative effect of accounting change
  $ 44,231     $ 12,513     $ (8,889 )   $ 47,855  
   
 
Basic income per common share
  $ 0.95                     $ 1.03  
Weighted average basic common shares outstanding (in thousands)
    46,464                       46,464  
Diluted income per common share
  $ 0.90                     $ 0.97  
Weighted average diluted common shares outstanding (in thousands)
    49,128                       49,128  

35



 

Notes to unaudited pro forma combined

financial information

The following adjustments were applied to our consolidated statements of operations and consolidated balance sheet and the financial statements of Kessler Rehabilitation Corporation.

  (a)  The elimination of $19.9 million of cash being held by Kessler Rehabilitation Corporation at June 30, 2003, that exceeded the target working capital of $34.4 million as specified by the stock purchase agreement. This excess cash was distributed to the selling stockholder prior to closing.